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Transient receptor potential vanilloid 2 channel (TRPV2) is a Ca2+-permeable ion channel that is highly
expressed in leukocytes but is also present in skeletal and cardiac muscle and endocrine cells. The TRPV2
function is implicated in a number of physiological processes, including bacterial phagocytosis, proinflammatory cytokine production, cardiac hypertrophy, and cancer development. TRPV2 knockout mice
exhibit a high incidence of perinatal mortality, arguing that the channel plays essential roles in physiology.
Despite the importance of TRPV2 for normal homeostasis, the mechanisms that control TRPV2 gating in
response to pharmacological agonists, heating, membrane stretch, bioactive lipids and reactive oxygen
species (ROS) remain poorly understood. Here we demonstrate that TRPV2 is functionally expressed in
microglia (i.e., ‘brain macrophages’) and the microglia-like BV-2 cell line, and demonstrate that the gating
of an endogenous TRPV2-like conductance is positively modulated by the bacterial toxin
lipopolysaccharide (LPS), which is known to cause pro-inflammatory (M1) activation and increase ROS
production by NADPH oxidase. To determine how TRPV2 gating is modulated by ROS, we recorded single
channel activity in inside-out patches excised from HEK-293 cells expressing GFP-rTRPV2. Unitary
currents elicited by the TRPV2 agonist 2-aminophenyl borinate (2-APB) or cannabidiol (CBD) are linear
in monovalent recording solutions and give rise to an estimated unitary conductance of ~100pS, which is
similar to TRPV1 but significantly smaller than TRPV3. Intriguingly, we find that although TRPV2 is
insensitive to ROS (in the form of exogenously applied H2O2) alone, apparent open probability is
synergistically enhanced when H2O2 is applied together with CBD. We identify two intracellular Cys
residues that are necessary for TRPV2 responses to H2O2 sensitivity and find that these residues are located
close to one another, albeit in different subunits, in the TRPV2 structure, suggesting that ROS promote the
formation of an inter-subunit disulfide bond that alters sensitivity to pharmacological agonists. We
hypothesize that ROS-dependent modulation of TRPV2 activity may be an important contributor to pro-
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inflammatory activation of microglia underline central nervous system diseases and that TRPV2
antagonism could be a useful therapeutic strategy in the treatment of neuroinflammation.

Chapter I. Introduction
1. The TRP channel superfamily
The superfamily of transient receptor potential (TRP) channel genes contains six subfamilies that encode
more than 20 different ion channel proteins in mammals2. TRP channels are grouped based on primary
sequence similarity rather than biological function, and include canonical (TRPC), vanilloid (TRPV),
ankyrin (TRPA), melastatin (TRPM), polycystin (TRPP) and mucolipin (TRPML) subfamilies3. Even
within a subfamily, sequence identity can be as low as 20%3. The overall architecture of TRP channel
proteins is similar to other voltage-gated cation channels: six transmembrane helices (S1 – S6) compose
the transmembrane-spanning structure and formation of a tetrameric quaternary structure is necessary for
function3. S5 - S6 and the intervening ‘pore loop’ from each of 4 subunits jointly form the pore domain that
contains the ion ‘selectivity filter’1,4-6.
A common theme among TRP channels is their weak selectivity between monovalent and divalent cations3,
and most TRP channels are thus permeable to the pleiotropic second messenger calcium (Ca 2+). Ca2+
permeability endows TRP channels with the ability to function as cellular sensors and to directly participate
in intracellular signaling cascades. When activated, TRP channels both depolarize the membrane (due to
inward currents carried by Na+ and/or Ca2+) and increase intracellular calcium concentration ([Ca2+]i) by
allowing an influx of Ca2+ from the extracellular space7. Physiologically, free [Ca2+]i is approximately 100
nM, which is significantly lower than the extracellular Ca2+ concentration (~2 mM); the Ca2+ concentration
gradient thus strongly favors Ca2+ entry over efflux2.
TRP channel gating mechanisms are crucial to understanding the biological functions of TRP channels.
TRP channel activation mechanisms are complex and vary widely even between members of the same
subfamily. A general feature of TRP channel gating is ‘polymodal gating’, in which multiple stimuli can
activate the same channel3,7. Examples include activation by membrane depolarization (i.e., voltage),
changes in temperature, mechanical force or membrane stretch, pharmacological ligands such as 2aminophyenyl borinate (2-APB), capsaicin (CAP), menthol and cannabinoids, membrane lipids (i.e.,
1

phosphatidylinositol(4,5)bisphosphate or PI(4,5)P2) and ions such as Ca2+ 3,7. TRPV1, TRPV2, and TRPV3
are activated by heating8-11, while TRPM8 and TRPA1 are known to be activated by cooling12-14. Gating in
each of the aforementioned channels is also modulated by changes in voltage, PI(4,5)P2 and chemical
ligands3,7,15-18. Some thermosensitive TRP channels contribute to thermal nociception: knockout of TRPV1
from mice, for example, attenuates behavioral responses to noxious heat and pain transduction19,20. Liganddependent activation of TRP channels also elicits specific behavioral responses. TRPV1 is activated by the
vanilloid compound capsaicin from hot chili peppers21, while TRPM8 and TRPA1 are activated by menthol,
a compound found in the mint plant; as a result, eating chili pepper causes the sensation of heat while mint
elicits a cooling sensation12,13.
The TRPV channel subfamily contains six members, (TRPV1 - TRPV6) that share 20% amino acid (aa)
identity. The TRPV subfamily can be further subdivided into two groups: TRPV1-4 and TRPV5-6 based
on the primary sequence: TRPV5 and TRPV6 share approximately 75% aa sequence identity, but are only
~20% identical to TRPV1-43,22. TRPV5 and TRPV5 are constitutively active (i.e., they lack gating
sensitivity to changes in temperature, voltage, and chemical ligands), and are thus distinct from TRPV143,7,22. TRPV1-3 share pharmacological activation by 2-APB, psychoactive and non-psychoactive
cannabinoids, sensitivity to heating, and are modulated by PI(4,5)P215,17,18. TRPV4 is distinct from TRPV13 in being mechanosensitive and activated by phorbol esters23,24. TRPV2 is most closely related to TRPV1,
with which it shares approximately 50% aa sequence identity7,8,22.
Despite recent advances enabling the cloning and functional expression of TRP channels in mammalian
cells, gating mechanisms, and physiological functions remain elusive. For example, the pharmacology of
activators and inhibitors at TRPV1 has been extensively characterized, biophysical properties have been
carefully analyzed, and physiological functions have been examined in transgenic animals4,7,22,25,26.
Recently, several TRPV1 structures in different conformations and in complex with different ligands were
solved by cryo-electron microscopy (cryo-EM), and the structural basis for vanilloid and PI(4,5)P2
sensitivity is known26-28. The recent availability of rat and rabbit TRPV2 cryo-EM structures have guided
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mutagenesis strategies to successfully reconstitute vanilloid sensitivity in TRPV2, suggesting that
differences in the molecular function of TRPV1 and TRPV2 are mainly attributable to specific amino acid
side chain substitutions1,29. The emergence of cryo-EM structures now facilitates other rationally designed
studies to investigate mechanistic similarities and differences between TRPV1 and TRPV2.

2. TRPV2 channel structure
The cytoplasmic N-terminus in TRPV2 contains a ~70 aa distal N-terminal region of the unknown structure
followed by the ~250 aa ankyrin repeat domain (ARD), and a ~60 aa membrane-proximal linker region that
connects the ARD to the S1 helix in the heptahelical transmembrane (TM) domain30. This distal N-terminal
region is not resolved by the crystal structure, suggesting its structure is dynamic31, and deletion of up to
65 N-terminal residues does not significantly alter channel function in rat TRPV232. Although their length
varies, ankyrin repeat domains are commonly found in TRP channels. In TRPV1 and TRPV2, the ARD
contains 6 interconnected ankyrin repeats each of which contains a similar helix-β-hairpin-helix motif1,29.
Ankyrin repeats stack to create the ARD, and the 5 consecutive β-hairpin structures (referred to as finger
1-5) compose a continuous external cytoplasmic surface1,29. ARDs are clearly resolved in cryo-EM
structures of TRPV2, suggesting that ARDs form relatively rigid structures31. Molecular dynamics (MD)
simulations of TRPV1 channels based on putative closed (apo)26 and open (bound to an activating peptide
toxin, DkTx, and the vanilloid compound resiniferatoxin)4 TRPV1 structures predict that channel opening
elicited by heat results from a sequence of conformational changes that begin in the intracellular ARDs;
rotation of ARDs relative to one another is thus thought to be a crucial step in the gating process33.
Reorganization of the ARDs subsequently causes changes in pore domain at both pore and cytoplasmic
gates, resulting in channel opening33. Heating could result in similar conformational changes, but a
definitive test of this hypothesis has not yet been reported.
The ARD (Fig 18A, purple) is connected to the TM domain (Fig 18A, cyan) by a highly conserved 60
amino acid helix-loop-helix (HLH) linker (Fig 18A, blue) that forms a V-shaped cradle at the membrane3

cytosol interface; the HLH linker is surrounded by the pre-S1 helix and TRP helix in both TRPV1 and
TRPV2 cryo-EM structures1,29 and the TRPV6 X-ray structure5. The pre-S1 helix directly connects S1 to
the ARD and the TRP helix (Fig 18A, 18B dark purple), which projects horizontally (i.e., parallel to the
membrane inner leaflet) from the cytoplasmic C-terminal domain (CTD; Fig 18A, green) of S6 underneath
the S1-S4 bundle1,29. Thus the HLH motif may transduce the movement of ARD to the transmembrane
domain and channel gate1,29. Consistent with this hypothesis, a chimeric TRPV1-TRPV2 channel protein
study indicated this region is crucial for thermal sensation in TRPV2, as swapping TRPV1 and TRPV2
cytosolic N-terminus can shift the thermal sensitivity between the two channels34.
The TM domain comprised of S1-S6 helical segments contains the vestigial S1-S4 voltage sensor domain
and pore (S5-S6) domains that are structurally homologous to voltage-gated K+ channels (Kv). The
selectivity filter regions in TRPV1 and TRPV2 contain a highly conserved Gly-Met-Gly-Asp/Glu motif
that is similar to the Gly-Tyr-Gly-Asp in K+ channel selectivity filter structures1,29. Pore architectures in
TRPV1 and TRPV2 differ slightly from one another, but the reasons remain unknown1. One possibility is
that differences in the purification methods used for TRPV1 and TRPV2 account for structural differences.
TRPV1 was purified in A8–35 amphipol while TRPV2 was purified using the maltose neopentyl glycol
(MNG) class of detergents1,4. Furthermore, some TRPV1 channel structures are stabilized by an activating
spider toxin (DkTx) or truncation of the extracellular S5 ‘turret’ region29,35. A prediction, based on
molecular dynamics simulation, is that the presence of the turret region would change the pore architecture
in TRPV136. The analogous turret region is present in TRPV2 cryo-EM expression constructs, but its
structure is poorly resolved in the structures, suggesting that this region is highly dynamic1.
The conserved TRP helix is connected to the C-terminal end of S6 and, as mentioned previously, extends
perpendicular to the S1-S4 helices to interact with the HLH linker domain via the pre-S1 helix, potentially
allowing allosteric communication between the transmembrane and the cytoplasmic regions of TRPV1 and
TRPV2 channels1,29. Studies in TRPV1 show that the TRP helix is likely to directly participate in PI (4,5)P2
binding site and to regulate desensitization of capsaicin- and heat-activated TRPV1 channel activity28,37.

4

Interestingly, the C-terminal end of the TRP helix in TRPV2 forms a hook-like structure (Fig. 18A, green)
that is absent from TRPV1 structures. The hook contains a series of ionizable amino acids and one Cys that
may be exposed, but the functional significance of this hook structure is unknown. At the C-terminal end
of the hook, the remaining CTD sequence forms an extended loop that forms part of the inter-subunit
interface together with the ARD (see Fig. 21)1,29. The CTD forms a single β-strand that contains C704/C748
(TRPV2/TRPV1) and is located adjacent to the N-terminal ‘finger’ formed by the ARD (Fig. 21); this βstrand is also close to the N-terminal helix of the proximal membrane linker domain and pre-S1 helix1,29.
Recent studies have shown that the CTD is crucial for inter-subunit interactions in TRPV channels. For
example, Ogawa, et al. (2016) show that in rTRPV1, C258 (C219 in rTRPV2) and C742 (C704 in rTRPV2)
form an intracellular disulfide bond under oxidizing conditions, and that C258S or C742S mutations prevent
the formation of the covalently-linked tetramer38. However, the atomic distances between sulphur atoms in
C258 and C742 (> 8 Å) appear to be too large to readily allow for inter-subunit disulfide bond formation
far away from their putative partners in participating in a disulfide bond (Fig. 21). Relatively subtle changes
in the local structures near C258 and C742 could enable inter-subunit interactions to influence channel
gating29,38, but the hypothesis that inter-subunit disulfide bonds influence TRPV1 gating has not been
directly tested. Given the similarity between TRPV1 and TRPV2 ARD structures, we hypothesize that
similar interactions could also occur in TRPV2. However, TRPV2 contains two Cys residues (C206 and
C334) at the inter-subunit interface that are not present in TRPV1; C219 and C704 in TRPV2 are equivalent
to C258 and C748 in TRPV1, respectively (Fig. 21). Thus the number of possible disulfide bonds that could
be formed in this region is larger in TRPV2, and intra- as well as inter-subunit bonds are each possible. No
studies have investigated the roles of Cys residues at the inter-subunit interface on TRPV2 channel function.
In summary, TRPV1 and TRPV2 cryo-EM structures are highly similar, suggesting that the structural basis
of gating are also likely to be shared. Movement of ARD domains in adjacent subunits are thought to
underlie temperature-dependent gating in TRPV1, and ARD interactions could also be important for
transducing other types of gating stimuli. Both N- and C-terminal residues contribute to the proposed ARD
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interaction motif, and the proximity of this structure to the TM domain and TRP helix is consistent with the
hypothesis that ARD motions function to control pore opening at the cytoplasmic gate. Differences between
TRPV1 and TRPV2 structures (i.e., hook structure at the C-terminal end of the TRP helix) could be
responsible for subtle but important differences in TRPV1 vs. TRPV2 gating. Finally, although the structure
of TRPV6 solved by X-ray crystallography5,6 exhibits remarkable overall similarity to TRPV1 and TRPV2
cryo-EM structures, ambiguity about the organization of subunits in TRPV6 complicates a direct
comparison of the ARD-TM interface. Future studies are needed to ascertain the relationship(s) between
channel structure and function in constitutively active (TRPV5 and TRPV6) vs. polymodal stimulusdependent (TRPV1-4) channels.

3. TRPV channel pharmacology
Synthetic and plant-derived small organic molecules are known to activate, block, or antagonize TRPV1-3
channels. In some cases, ligands (i.e., capsaicin) are selective for one channel isoform or species orthologue;
other agents (i.e., 2-APB) act similarly to agonize TRPV1-3 but antagonize other TRP channels; and some
ligands (i.e., ruthenium red; RuR) universally modulate most or all TRP channels 22,39,40. Selective ligands
have been useful for identifying TRP channels and dissecting their physiological roles. For example,
TRPV1 is potently activated by the plant-derived vanilloid compound capsaicin, and this activity was
instrumental in the initial identification and cloning of TRPV1 from mRNA in dorsal root ganglion
neurons11,22. Capsaicin also functions as a neurotoxin that can be used to selectively ablate TRPV1expressing cells during development41. In contrast, TRPV2 and TRPV3 are essentially capsaicininsensitive3,8,42. However, limited mutagenesis was used to show that TRPV2 can become vanilloidsensitive, suggesting that the binding pockets are conserved and functional differences are attributable to
specific interactions between drug molecules and protein side chains43.
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Phytocannabinoids, including Δ9-tetrahydrocannoiabinol (THC) and cannabidiol (CBD), which are
psychoactive and non-psychoactive compounds, respectively, isolated from the marijuana plant, act as
agonists of TRPV1 and TRPV2 with similar (micromolar) potency44. Although the cannabinoid binding
site is not known, studies suggest that it may be least partly overlap with the vanilloid binding site. The
putative PI(4,5)P2 binding site also partially overlaps with the vanilloid binding site in TRPV1, suggesting
a common mechanism of gating modulation by phosphoinositides45. Although PI(4,5)P2 is reported to
negatively affect channel open probability (PO) in both TRPV1 and TRPV346-48, contrasting reports suggest
that TRPV1 and TRPV2 may also be positively gated by PI(4,5)P2 and other phosphoinositide 18,49,50, and
the existence of additional interaction sites in TRP channel has not been ruled out.
TRPV1-3 are also commonly activated by 2-APB, which functions as an antagonist at other ion channel
targets27. Membrane depolarization, 2-APB, heating, and PI(4,5)P2 appear to cooperatively gate TRPV1
and TRPV3 channels, suggesting that these disparate stimuli impinge on a common downstream gate3.
Voets, et al. and Brauchi, et al. proposed allosteric gating schemes to explain cooperative gating by diverse
stimuli51,52. The reason(s) why TRPV2 appears to exhibit different sensitivities to voltage, heating, and
PI(4,5)P2 remain to be determined. Interestingly, 2-APB potency is ~10-fold lower in human vs rat TRPV2,
and residues in the ARD appear to be responsible for this difference32. This suggests that 2-APB could
directly interact with residues that are near the putative ARD interaction motif (i.e., close to C748 in
TRPV1) described earlier32. However, the existence of additional 2-APB binding sites in TRPV1-3 has not
been ruled out. Ruthenium red serves as a voltage-dependent pore blocker in a number of TRP channels
and exerts its effect by binding voltage-dependently in the selectivity filter region of the TRPV4 pore
domain8. Consistent with this hypothesis, extracellular RuR rapidly and potently blocks inward currents in
many TRP channels, but outward currents block is less robust (see Figs. 4, 5).
Although TRPV2 pharmacology is less well characterized than TRPV1, two synthetic compounds are
reported to selectively modulate TRPV2. Probenecid (PBC), a blocker of organic cation transport,
selectively activates TRPV2 (EC50 = 32 μM), as measured by calcium imaging47. Neither the molecular
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determinants of the putative PBC binding site nor the drug’s mechanism of action at TRPV2 has been
reported. TRPV2 is also reported to be selectively antagonized by anti-allergic medicine tranilast
(Rizuben)46,53-55. Together with commonly used TRPV channel agonist 2-APB and CBD, synthetic
compounds provide a limited but useful tool for identification of TRPV2 channel current.

4. The physiological role of TRPV2
The physiological roles of TRPV2 are not well established, but the severe phenotype (which includes a high
incidence of perinatal lethality) in a constitutive, global TRPV2-null transgenic mouse line argues that
TRPV2 channels are likely to be necessary for a broad variety of essential physiological processes56. In
contrast, knockout of TRPV1, TRPV3 or TRPV4 in mice does not lead to overt morphological defects or
loss of viability19,20,57-59. Similar to TRPV1-4, TRPV2 channel is activated by heating, but the apparent
thermal activation threshold for expressed TRPV2 (>52° C) is supra-physiological8. In contrast to TRPV1
knockout mice20, TRPV2-null mice do not manifest behavioral deficits to thermal stimuli56, indicating that
TRPV2 is not responsible for heat sensation.
In contrast to other TRPV channels, TRPV2 is abundantly expressed in the immune system. TRPV2 mRNA
is expressed in high amount compared to other TRPV channels in human blood lymphocytes60. Ca2+permeable ion channels of the Transient Receptor Potential (TRP) family are also reported to be expressed
in both macrophages and microglia, where they may mediate Ca2+ entry and thereby modulate inflammatory
activation. Both TRPV1, TRPV4 protein have been reported to present in microglia61-63. TRPV2 is reported
to be present in macrophage64-66, and recently in BV-2BV-2 microglia like-cells67. RNA interference
(RNAi)-mediated knockdown of the TRPV2 or pharmacological block by ruthenium red (RuR)
dramatically attenuates lipopolysaccharides (LPS)-induced interleukin 6 (IL-6) production and nuclear
factor kappa-light-chain-enhancer of activated B cells (NF-κB) nuclear translocation in the macrophagelike RAW264 cell line66. As expected from the inhibition of NF-κB nuclear translocation, LPS induced
transcription of pro-inflammatory cytokine tumor necrosis factor alpha (TNFα) and interleukin 1 beta
8

(IL1β) are attenuated in TRPV2 knockdown macrophage66. Targeted deletion of TRPV2 in mice causes a
defect in peritoneal macrophage phagocytosis64. However, one contradicting result shows that the targeted
deletion of TRPV2 in mice did not alter IL6 production64. The reasons for contradictory results are
unknown, but the difference may potentially be compensation mechanisms in cytokine production. Finally,
TRPV2 is associated with podosome formation in the macrophage. The addition of the chemokine formylMet-Leu-Phe (fMLP) peptide has been shown to cause translocation of TRPV2 from cytosol to
podosome65,68. The translocation of TRPV2 to podosome is coupled by elevated basal calcium level in the
cell68. Removal of extracellular Ca2+ abolishes the elevation of basal calcium level in macrophage,
indicating calcium influx is the cause of elevated basal [Ca2+]i 65,68. Furthermore, knockdown of TRPV2 as
well as the application of TRPV channel blocker ruthenium red (RuR), prevents the elevated basal [Ca2+]i
following fMLP peptide stimulation65,68, indicating TRPV2 channel translocation and activation in
podosome is needed to mediate fMLP induced Ca2+ influx and macrophage motility.
TRPV2 is also suggested to be functionally expressed in other leukocyte cell lines, including RBL-2H369
and Jurkat70 cells. Leukocytes also express a variety of other TRP channels that can be discriminated based
on pharmacological criteria39. Endocannabinoids44 and lysophosphatidylcholine (LPC)71,72, which activate
both TRPV1 and TRPV2 channels. Both TRPV1 and TRPV2 channels are reported to be expressed in BV2BV-2 cells67, which are widely used as a cell culture model for microglia73. However, it is not known
whether TRPV2 is expressed in primary microglia cells. Whether TRPV3 is expressed in BV-2BV-2
microglia is not known. Although TRPV1 and TRPV2 are thermosensitive, the apparent threshold for
temperature-dependent gating of expressed TRPV2 channels (~52˚ C) is well above the physiological
range8. In contrast, studies indicate that TRPV2 is an important mediator of immune cell function. Despite
knockdown and knockout studies indicate the importance of TRPV2 in macrophage phagocytosis64, LPS
induced NF-κB nuclear translocation66, cytokine production66, and chemotaxis65,68; the mechanism of
TRPV2 activation in immune cells remains poorly understood.
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5. TRPV channels in microglia
Microglia are innate immune cells of the central nervous system (CNS). Microglia are phagocytes derived
from a common myeloid lineage as monocytes, neutrophils, and osteoclasts74. They comprise
approximately 12% of cells in the mammalian brain75. Microglia in the brain is thought to exist in a ‘resting’
state under normal physiological conditions76,77. Resting microglia are characterized by a small cell body
with highly ramified processes, dynamically extending and contracting for continuous surveillance of the
surrounding environment77. Microglia is readily activated by traumatic injury or immunological stimuli77,78;
once activated, microglia can mediate both beneficial and detrimental functions75,79,80.
Microglia, by design, is capable of recognizing and responding to diverse stimuli. Factors known to activate
microglia include molecules of infectious agents, damaged neuronal cells, environmental toxins, cytokines,
chemokines, and heavy metals76,78,81-84. Despite the wide variety of the potential stimuli common factors
can be found to modulate microglia activation. One common signaling molecule is hydrogen peroxide
(H2O2)75. Microglia, macrophages and other phagocytic leukocytes produce reactive oxygen species (ROS)
including superoxide (O2-·) after exposure to pro-inflammatory stimuli, including bacterial peptides (i.e.,
fMLP) and the endotoxin lipopolysaccharide (LPS)76. O2-· is readily converted to membrane-permeable
H2O2 85, and H2O2 is suggested to alter the function of TRPV1, TRPV486, TRPM287,88 and TRPA1

89-91

.

Autocrine or paracrine signaling by H2O2 and other ROS positively modulates inflammatory activation of
leukocytes. In the CNS, ROS-dependent reactive microgliosis appears to contribute to neurotoxicity
associated with environmental toxicants, ischemic damage following stroke, neurodegenerative diseases,
and age-related cognitive impairment75,76. Ca2+ influx through TRP channels has not been directly linked to
leukocyte pathophysiology, but redox modulation of TRP channel gating nonetheless represents a
compelling mechanistic hypothesis that has not previously been tested.
A rise in the concentration of [Ca2+] i is required for inflammatory activation of phagocytic leukocytes such
as macrophages and microglia85,92,93. For example, chelation of [Ca2+] i by incubation of macrophages with
BAPTA-AM reduces lipopolysaccharide (LPS)-dependent cytokine and nitric oxide production85. Other
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markers of inflammatory activation in macrophages, including nuclear translocation of NF-κB, production
of cytokines such as TNFα, and NLRP-3 inflammasome formation also require elevated [Ca2+] i 92-95. Since
nuclear translocation of NF-κB is required for transcription of pro-inflammatory genes, and NLRP-3
inflammasome is required for the production of the mature form of IL-1β in macrophage and microglia, the
ion channels regulating the basal [Ca2+] i can play a significant role in regulating macrophage and microglia
activation. As demonstrated by Nagasawa et al, TRPV2 channels may mediate the Ca2+ influx from the
extracellular fluid into macrophages, and perhaps it is not surprising that knockdown of TRPV2 attenuates
LPS induced nuclear translocation of NF-κB and cytokine production in macrophages66.
Here we hypothesize that similar to the related TRPV1 and TRPV3, TRPV2 channels are also regulated by
H2O2 and mediate calcium influx in microglia like cells. In this thesis, we examine both previously unknown
TRPV2 channel gating characteristics and enhanced activation of TRPV2 by pro-inflammatory stimuli such
as LPS and H2O2. Specifically, we demonstrate that 1. TRPV2 have similar single channel properties
compared to TRPV1; 2. TRPV2 single channel properties can be modulated by pharmacological reagents;
3. TRPV2 are functionally expressed in both BV-2BV-2 and primary mouse brain microglia; 4. Application
of exogenous H2O2 is sufficient to potentiate the agonist-dependent activity of expressed TRPV2 channels;
5. Acute treatment of microglia with LPS is sufficient to positively modulate the gating of endogenous
TRPV2 currents. Our results suggest that endogenously produced ROS in macrophages and microglia is
likely to augment Ca2+ influx through TRPV2 channels and thereby exacerbate pro-inflammatory leukocyte
activation.
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Chapter II. Method
1. Cell culture
Human embryonic kidney 293 (HEK-293) cells and murine BV-2 microglia-like cells (BV-2, a generous
gift from Dr. Michelle Block; Stark Neurosciences Research Institute, Indiana University School of
Medicine, Indianapolis, IN) are cultured in Dulbecco's modified eagle's medium (DMEM) media with 10%
fetal bovine serum (FBS) and 1% penicillin and streptomycin (P/S) solution. Culture enriched in neonatal
mouse microglia (a generous gift from Dr. Michelle Block; Stark Neurosciences Research Institute, Indiana
University School of Medicine, IL and Dr. Pamela Knapp; Department of Anatomy and Neurobiology,
Virginia Commonwealth University, VA) are cultured in DMEM media with 2% FBS and 1% P/S solution.
The cells are maintained at 37°C under 5% carbon dioxide (CO2) environment until the experiment.
Prior to the experiment, enhanced green fluorescent protein (EGFP)-tagged rat-TRPV1 (rTRPV1), ratTRPV2 (rTRPV2) or human-TRPV3 (hTRPV3) channels cloned into the pEGFP-C1 vector (Clontech) are
transfected into HEK-293 cells with Lipofectamine 2000 reagent (Invitrogen) following manufacture's
protocol. Briefly, 0.5µg of plasmid DNA is mixed with Lipofectamine 2000 in Opti-MEM (Gibco) solution.
Plasmid DNA is allowed to mix with Lipofectamine 2000 at room temperature for 30 minutes, and then
DNA-Lipofectamine solution is applied to HEK-293 cells. HEK-293 cells are cultured at 37°C with 5%
CO2 for at least 8 hours to ensure successful transfection. Transfected HEK-293 cells are incubated at 37°C
for at least 24 hours prior to the experiment.
BV-2 cells and neonatal murine primary microglia enriched cultures are incubated with either treatment
media (DMED media with 2% FBS and 1% P/S) or treatment media containing 2µg/ml in at 37ᵒC for 2030 minutes prior to experiments.
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2. TRPV channel mutagenesis
Site-directed point mutations are introduced into TRPV channels by polymerase chain reaction (PCR), and
then cloned into HEK-293 cells. The mutagenesis primer is designed by either SeqBuilder software
(DNASTAR Lasergene 8) or Serial cloner software (Serial Basics) and synthesized by Integrated DNA
Technologies, Inc. PCR reactions are prepared by mixing 25μl of Phusion® High-Fidelity DNA
Polymerase (New England Biolab, Inc.), with 100ng DNA, 300ng forward and reverse primers, 4μl
Dimethyl sulfoxide (DMSO) and 17μl distilled water. The cyclic parameters of PCR are 98°C for 1 minute
followed by 20 cycles of 98°C for 1 minute, 50°C for 1 minute, and 72°C for 5 minutes. Methylated DNA
are removed from PCR products by DPN1 digestion, 37°C for 1 hour. PCR products are then transformed
into XL10-Gold® Ultracompetent Cells (Stratagene) according to manufacturer’s protocol. Briefly, XL-10
gold cells are defrosted on ice and mixed with 1μl Dimethyl sulfoxide (DMSO). PCR products are then
added to XL10 gold cells and incubated on ice for 30 minutes. XL-10 gold cells are then subjected to 42°C
heat shock of either 30 or 45 seconds and incubated in 200ml super optimal broth with catabolite repression
(SOC) medium in 37°C for 1 hours. Transformed E.coli are then selected on Luria broth (LB) agar plate
with 30μg/ml kanamycin incubated for at least 24 hours in 37°C. Surviving colonies are selected and
cultured in LB broth with 30μg/ml kanamycin are incubated for at least 24 hours at 37°C. Finally, plasmid
DNAs are isolated using QIAprep Spin Miniprep Kit (Qiagen).
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3. Preparation of TRPV agonists and antagonists

Table 1 Agonist and antagonist of TRP channels.

Compound name
2-Aminoethoxydiphenyl borate
Allyl isothiocyanate
Capsaicin
Cannabidiol
Hydrogen peroxide
Probenecid
Capsazepine
4-[(2-Butyl-6,7-dichloro-2-cyclopentyl2,3-dihydro-1-oxo-1H-inden-5yl)oxy]butanoic acid
Ruthenium Red
Tranilast

Abbreviation
2-APB
AITC
CAP
CBD
H2O2
PBC
CZP
DCPIB

Functions
TRPV1-3 agonist
TRPA1 agonist
TRPV1 agonist
TRPV1, V2 agonist
ROS
TRPV2 agonist
TRPV1 antagonist
Swell activated Cl
channel antagonist

Solvent
DMSO
DMSO
DMSO
Methanol
H2O
DMSO
DMSO
DMSO

RuR
Tra

Ca channel blocker
TRPV2 antagonist

H2O
DMSO

Compound name and their abbreviation are listed with their targeted TRP channel and solvent used to create
stock solutions. All compounds are diluted by bath solution and applied by bath superfusion or pipetting.

The compounds used for electrophysiology are listed above. 2-APB (Cayman chemical) is prepared in
dimethyl sulfoxide (DMSO; Fisher Scientific) as concentrated stock, and diluted and applied to cells by
bath superfusion as non-selective TRPV channel agonist. AITC (Sigma), CAP and PBC (Cayman chemical)
are prepared in DMSO as concentrated stock, and then diluted and applied to the cells by bath solution
superfusion as a TRPA1, TRPV1, and TRPV2 selective agonist respectively. CBD (Cerillant) is prepared
in methanol (EMD Millipore Biochemicals) as concentrated stock and diluted and applied to the cell by
pipetting as a TRPV2 agonist. H2O2 (EMD Millipore Biochemicals) is prepared in HyClone HyPure
Molecular Biology Grade Water (Thermo Scientific) and applied to the cell by pipetting to enhance TRPV2
current. CZP (Cayman chemical), DCPIB (generous gift from Dr. Clive Baumgarten, Department of
Physiology and Biophysics, Virginia Commonwealth University, VA) and Tranilast (Toics Bioscience) are
prepared in DMSO as concentrated stock, and then diluted and applied to cell by bath superfusion as TRPV1,
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swell activated chloride channel (ICl,swell) and TRPV2 antagonist respectively. Finally, RuR (Cayman
chemical) is prepared in HyClone HyPure Molecular Biology Grade Water as concentrated stock, and then
diluted and applied to the cell by bath superfusion or pipetting to block TRP channels.

4. Immunocytochemistry
Non-treated HEK-293 cells, EGFP-tagged-rTRPV2-transfected HEK-293 cells, EGFP-tagged-hTRPV3treansfected HEK-293 cells, BV-2 cells or dissociated neonatal mice primary microglia cells are plated onto
glass coverslips. Cells on coverslips are then washed with ice-cold Phosphate-buffered saline (PBS), and
then fixed by incubating in 4% paraformaldehyde containing PBS (American bioanalytical) solution for 30
minutes to 1 hour. Fixed cells are permeabilized by 0.1% Triton X-100 (Sigma) for 1hour, and blocked
with 1% bovine serum albumin (BSA) containing PBS solution for 1 hour. Following permeabilization,
serial exposure to rabbit anti-TRPV2 (1:1000 dilution, Oncogene), rabbit anti-TRPV3 antibody (1:1000
dilution, custom antiserum, the gift of Dr. David E. Clapham, HHMI, Children’s Hospital Boston) or mouse
anti-TRPA1 antibody (1:1000 dilution; Alomone Labs) at 4ᵒC overnight. After overnight incubation cells
are subjected to incubation with Alexa fluoro647 secondary antibody (1:1000 dilution, Cell Signaling
Technology) for 1 hour at room temperature. Fluoregel with tris buffer (Electron Microscopy Science) is
applied to preserve immunofluorescence. Images are captured by confocal laser scanning microscopy
(Olympus LSM710, VCU Department of Anatomy and Neurobiology Microscopy Facility, supported in
part by funding from NIH-NINDS Center core grant 5P30NSD47463). The images are captured and
processed by ZEN software (Carl Zeiss). The fluorescence intensity was normalized to positive control
(EGFP-tagged-rTRPV2 or EGFP-tagged-hTRPV3-transfected HEK-293 cells).
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5. Western blotting
HEK-293 cells transfected with rTRPV2 or hTRPV3 and BV-2 microglia like-cells are grown in a 10cm
petri-dish until reaching approximately 90% confluency. Cells are collected by scraping in cold PBS. BV2 cells are lysed in 1% Triton X solution with complete mini protease inhibitor (Roche Diagnostics) in PBS,
and protein is collected from the supernatant of whole cell lysate after spinning 15,000xg for 10 minutes.
Protein concentration is measured by Pierce BCA protein standard assay (Thermo Scientific) according to
the manufacturer’s protocol. Then proteins are denatured by heat and 2-Mercaptoethanol (BME; MP
Biomedicals). Proteins are separated by size by SDS-PAGE using Mini-PROTEAN Tetra System (Biorad)
for 100 to 120 V for 1 to 2 hours. Separated proteins were transferred onto PVDF transfer membrane
(Thermo Scientific) using Pierce fast semidry blotter (Thermo Scientific) for 15V for 1 hours. PVDF
transfer membrane is exposed to rabbit anti-TRPV2 (1:1000 dilution Oncogene), rabbit anti-TRPV3
(1:1000; dilution custom antiserum, gift of Dr. David E. Clapham, HHMI, Children’s Hospital Boston),
mouse anti-TRPA1 (1:1000 dilution; Alomone Labs) or mouse anti-βactin (1:1000 dilution, Chemicon)
described above in 4ᵒC overnight. HRP-conjugated goat anti-mouse or HRP conjugated goat-anti-rabbit
antibody (1: 1000; Pirce) is applied for 1 hour at room temperature on the following day. Finally, PVDF
transfer membrane is developed by Supersignal West Pico reagent (Thermo Scientific) and developed on
Blue Ultra Autorad Film (GeneMate).

6. Electrophysiological recording
HEK-293 cells expressing EGFP-tagged rTRPV1, EGFP-tagged rTRPV2, EGFP-tagged hTRPV3, BV-2
cells, or dissociated neonatal mouse primary microglia are plated onto glass coverslips and maintained at
37°C with 5% CO2. Whole cell voltage clamp electrophysiology is performed in a bath solution containing
approximately (in mM) 150 NaCl and 2 MgCl2 1 EGTA, 10 HEPES, pH 7.4. The pipette solution contains
(in mM): 150 CsMeSO3, 2 MgCl2, 10 NaCl, 2 CaCl2, 1 EGTA, 10 HEPES pH 7.4. Final [free Ca2+]i is ~100
nM (estimated using Maxchelator, C. Patton, Stanford University). The osmolality of the bath and pipette
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solutions is adjusted to 290-310 mmol/kg. Currents were elicited by repeated application of 1 s voltage
ramps (-80 to +80 mV with 10 kHz sampling rate, repeated every 4 seconds) or voltage step (-80 to 120mV
voltage step followed by -80mV voltage step, 10 kHz sampling rate). Currents are low-pass filtered at 5
kHz and digitized at 20 kHz. Single channel currents are measured by the excised inside-out patch clamp
technique. Excised inside-out patches are pulled from cells into symmetrical bath and pipette solutions
containing (in mM): 150 NaCl, 1 EGTA, 10 HEPES, pH 7.4. Osmolality is adjusted to 290-310mmlo/kg.
Single-channel currents are measured during repeated voltage steps (1 or 2s duration at 15 kHz sampling
rate, repeated every 5 seconds). Membrane voltage is stepped to +80mV and -80mV unless otherwise
indicated. Currents were low-pass filtered at 2 kHz and digitized at 15 kHz. Data are captured by
JustAcequire program and analyzed by Clampfit 10 software (Molecular devices).

7. Analysis of electrophysiological recordings
a. Whole cell recording analysis
The whole cell voltage clamp recording is processed and analyzed by Clampfit 10 software (Molecular
devices) and Origin 6.0 (Origin Lab). In the voltage ramp and voltage step protocol, membrane currents are
recorded in the form of current change over time (I-t plot). Raw data are presented as I-t curves where time
(ms) is presented in the x-axis and current is presented in the y-axis (nA; see F4B, result). The ramp protocol
consist of 50 or 300ms -80mV step to measure steady state -80mV step current, followed by voltage ramp
consistently increase membrane potential from -80mV to +80mV in 1s to construct an current-voltage (IV) curve, followed by a 100ms +80mV membrane step to measure steady state step +80mV current, and
finally a 500ms -80mV membrane step to measure -80mV instantaneous tail current (Itail; see F4A, result).
The voltage ramp is repeated every 4 seconds. In the voltage step protocol, membrane potential is stepped
to -60mV for 200ms, and then stepped to various membrane voltage for 500ms. Finally, membrane voltage
is stepped to -80mV for 300ms to measure Itail (see F36A, result section).
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b. Construction of Current-Voltage relation curve (IV curve)
The -80 to 80mV ramp protocol is used to construct IV curve of TRPV channel. In the voltage ramp protocol,
membrane potential is raised from -80mV to +80mV in 1 second. Hence the voltage (V) at any given time
is time is expressed in following formula.
𝑉 = −80 + ((𝑡 − 𝑡0) • 0.16)
Equation 1: Equation for time to voltage conversion
Voltage ramp over 1 seconds raised membrane potential from -80mV to +80mV. The membrane voltage at any
given time is proportional to time (t) minus time of voltage ramp start (t0) multiple by 0.16 and minus 80.

After membrane voltage is determined, IV curves are constructed by plotting voltage (mV) in the x-axis
and corresponding current (nA) in the y-axis.

c. Analysis of tail current
Instantaneous tail current is used to measure the apparent open probability of the channel. Itail is determined
by fitting tail current measured to exponential decay function shown below.
𝑓(𝑥) = 𝑓0 𝑒 −𝑡⁄𝜏
Equation 2: Exponential decay function
The exponential decay function is used to determine the instantaneous tail current (Itail). Tail current at any given
time denoted f(x) is calculated by multiplying e –t/τ to tail current at the change of voltage (equals to instantaneous
tail current, Itail). e is Euler's number, t is the time of measurement and τ is the time constant of decay function.

Itail-V curve is constructed by plotting Itail (y-axis) across varying step voltage (x-axis), and then the Itail-V
curve is fitted to Boltzmann equation shown below.
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𝐼𝑡𝑎𝑖𝑙 =

(𝐼𝑡𝑎𝑖𝑙 𝑚𝑎𝑥 ) − (𝐼𝑡𝑎𝑖𝑙 𝑚𝑖𝑛 )
1+

𝑉0.5
𝑒 𝑉− 𝑑𝑥

+ 𝐼𝑡𝑎𝑖𝑙 𝑚𝑖𝑛

Equation 3: Boltzmann equation
Boltzmann fit to Itail-V relations is used to describe voltage needed to achieve 50% of the maximum tail current
(V0.5) and slope factor (dx). Itail max is the largest instantaneous tail current measured and Itail min is the smallest
instantaneous tail current measured. V denote step voltage and e is Euler's number.

d. Single channel recording analysis
Single channel recording is processed and analyzed by Clampfit 10 software (Molecular devices) and
Origin 6.0 (Origin Lab). For samples with large noise, inside-out patch clamp data were subjected to offline
digital low-pass filtering (500 Hz) for analysis and presentation. Subsequently, the leak current is subtracted
by subtracting the average of 10-20 seconds of the control current from all recorded currents. In experiments
where leak current is changing, further leak subtraction is performed manually. Once current are normalized
to control, the data are presented as in form of i-t curve where time is plotted in the x-axis and current
response plotted in the y-axis. In addition to the i-t plot, following analysis are performed using normalized
single channel recording.

e. Construction of all point histogram and unitary conductance measurement
The all point histogram are used to summarize the channel activity and measures the unitary current of
TRPV channels. Raw current recording across 18 seconds (unless otherwise indicated) are summarized into
all point histogram with the x-axis plots current and the y-axis plots the event count. The histogram is then
fitted by multiple Gaussian curves shown below.

𝑦 = 𝑦0 +

𝐴
𝑤√𝜋/2

Equation 4: Gaussian equation
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𝑒

−

(𝑥−𝑥𝑐)2
𝑤2

Gaussian fit to all point histogram is used to describe numbers of open channel event (y) at any given current
(x). y0 is the base of the Gaussian curve, A is the area under the Gaussian curve, w is the width of the Gaussian
curve, xc describe the center of the Gaussian curve, π is circle constant and e is Euler's number. The unitary
current (i) is described by xc of open channel peaks.

The histogram is normalized to close channel by subtracting center of the Gaussian curve of the closed
channel (xc closed) from all Gaussian fits, making the center of xc closed always equal zero. The center of
the Gaussian curve of open channel (xc open) is measured to determine unitary current of the TRPV
channels. In order to compare the unitary current between different voltage steps, unitary conductance is
calculated as follow.
𝑖 = 𝛾 ∙ (𝑉𝑀 − 𝐸𝑅𝐸𝑉 )
Equation 5: Equation for unitary conductance
Unitary current (i) is proportional to unitary conductance (γ) by the driving force, which depends on membrane
potential (VM) and the ‘reversal’ potential (EREV) of current flowing through the open channel. The symmetrical
solution is used to measure single channel activity and EREV is expected to be 0.

f.

Single channel event detection

The current measured in whole cell voltage clamp electrophysiology can be denoted as
𝐼 = 𝑁 ∙ 𝑖 ∙ 𝑃𝑂
Equation 6: Whole cell current
Whole cell currents (I) is proportional to the product of the number of functional channels in the cell membrane
(N), the amplitude of unitary current (i), and PO.

To better understand TRPV2 channel gating properties, it is important to measure both i and PO. The
channel open probability (PO) are detected using single channel search function (Clampfit 10, Molecular
Devices) after the unitary current is determined by the Gaussian fit of all point histogram (see above). The
single channel search function measures the fraction of time TRPV channels spends in open channel stated
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compared to the time TRPV channel spend in closed channel states. First, a baseline for the level of current
associated with the closed-channel state is manually defined. Next, events corresponding to channel
openings of discrete, pre-defined amplitude (i.e., at +80 mV, i ≈ 6 pA for TRPV1, i ≈ 6 pA for TRPV2 and
i ≈ 10 pA for TRPV3; see Results) are automatically detected and counted. The investigator can manually
include or exclude ambiguous events in the event count, and currents within ~10% of the expected
amplitude are accepted as normal variability. To measure events associated with fully open channels, only
channel openings lasting more than 0.1 ms are included in the event-based analysis. The single channel
search in Clampfit 10 reports statistics associated with events detected in each recording, including mean
open

and

closed

times,

average

single

channel

amplitude,

and

the

product

of

N

·

PO (NPo).

8. Statistical analysis
Statistical analysis is conducted by Origin 6.0 software or online statistical computation tools such as
Verssarstat (www.verssarstat.net), or Graphpad website (http://www.graphpad.com).
Three statistical methods are used. The student t-test is used to compare two independent groups. Paired
student t-test are used for statistical analysis of measurements between same cells. One-way ANOVA
followed by Tukey's honest significance test are used for statistical analysis between more than three groups.
Statistical significance is reached if the difference between groups reaches greater than 95% confidence
interval. Results are presented in the form of mean ± standard error of the mean (SEM) unless otherwise
noted.
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Chapter III. Results

Figure 1: TRPV2 channels are activated by 2-APB and blocked by RuR.
A representative HEK-293 cell expressing EGFP-rTRPV2 is voltage clamped in the whole-cell mode and
currents were elicited by voltage ramps (A) from -80 mV to +80 mV (1s duration, 0.25Hz). B. Currents elicited
by the voltage protocol shown in A are measured in the absence (a. control, black line) or presence of 500 μM
2-APB (b., green line) or 500 μM 2-APB + 10 μM ruthenium red (RuR; c., magenta line). Letters refer to the
time at which currents were measured (see panel D). Note that a prominent ‘tail’ current (§) is measured at -80
mV only in the presence of 2-APB. C. I-V relations determined during the linear portion of the voltage ramp
protocol (indicated by # in panel A) are measured in the absence and presence of 2-APB and RuR (data from
panel B) and plotted in function of membrane potential. D. Steady-state current (*; Istep, +80mV) and
instantaneous tail current (§; Itail, -80mV) elicited by voltage steps at the times indicated in panel B are measured
over the duration of the experiment and plotted in function of time. Note that the time course of current activation
by 2-APB is relatively slow, but appears to reach a steady-state after ~20 s, whereas RuR block of inward current
is rapid. Letters indicate times at which the currents shown in panels B and C were measured: a., control; b., 2APB; c., 2-APB + RuR.

1. Pharmacological property of the TRPV2 channel
TRP channels are characterized by their ‘polymodal’ sensitivity to multiple different stimuli7,22. TRPV2 is
activated by heat, membrane depolarization, and organic compounds such as 2-APB27,96, PBC47, and
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phytocannabinoids, including 9-THC44 and CBD44,97. To study gating properties of TRPV2, we use a
combination of membrane depolarization and pharmacological stimulation. HEK-293 cells were
transiently transfected with cDNA encoding an enhanced green fluorescent protein (EGFP)-rat TRPV2
(GFP-rTRPV2) fusion protein (Method 1) and subjected to whole cell voltage clamp (Method 6). A
voltage ramp protocol from -80 mV to +80 mV (1 s duration) is repeatedly (20 kHz) delivered to the cell
in the absence and presence of pharmacological agents applied by bath superfusion (Fig. 1A). A small
background current is observed under control conditions (Fig. 1B, black line). As expected from previous
studies27,96 superfusion with the non-selective TRPV channel agonist 2-APB elicits a robust TRPV2
current (Fig. 1B, green line) that is voltage-dependently blocked by co-application of RuR together with
2-APB (Fig. 1B, magenta line). 2-APB is reported to activate rat TRPV2 (EC50 = ~130 μM) but not able
to activate human TRPV232,96, and the large current observed in our studies is consistent with the
hypothesis that rTRPV2 open probability (PO) is high under our experimental conditions. 2-APB
activation of TRPV1-3 is also characterized by strong positive cooperativity, which is manifested as a
steep Hill slope27,43, and we also observe that a slightly lower concentration of 2-APB (100 μM) elicits
small or undetectable TRPV2 currents (data not shown).
Voltage-dependent activation of rTRPV2 is fast, so currents elicited by slow voltage ramps can be used to
generate quasi-steady-state current-voltage (I-V) relations (Fig. 1C). The amplitude of 2-APB activated
currents in cells expressing TRPV1-3 varies with stimulus strength (i.e., agonist concentration, duration of
agonist exposure and membrane potential)25,98-100. In the representative cell expressing rTRPV2 shown in
Figure 4, 2-APB (500μM) elicits an I-V relation that exhibits weak outward rectification (Fig. 1C). Large
‘tail’ currents (measured at -80 mV instantaneously following the voltage steps to either 0 mV or +80 mV;
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Figure 2: TRPV2 currents are activated by probenecid (PBC) and cannabidiol (CBD) and
inhibited by tranilast.
Currents elicited by voltage ramps (see Fig. 1) are measured in a representative HEK-293 cell expressing
EGFP-rTRPV2 and superfused with the indicated drugs. A. PBC (4 mM) induces an outwardlyrectifying current (green line) that is voltage-dependently blocked by co-application of RuR (10 μM)
and PBC (magenta line). B. PBC (4 mM) induces a current with a linear I-V relation (green line) that is
blocked by co-application of 1 μM Tranilast (magenta line). C. CBD (300 μM) induces an outwardlyrectifying current (green line) that is inhibited by 10μM RuR (magenta line). In A-C, black lines indicate
current measured in the presence of vehicle alone (control).

Fig. 1B) are consistent with previous reports demonstrating depolarization-dependent activation of TRP
channels27,51.48,101 Instantaneous tail current (Itail) is observed in the presence of 2-APB, but not under control
conditions (Fig. 1B), indicating that voltage-dependent gating is enhanced in the presence of a TRPV2
agonist. Itail elicited by the initial hyperpolarization to -80 mV indicates that some TRPV2 channels are
open at 0 mV; the larger inward tail current measured at -80 mV after a depolarizing voltage ramp and step
to +80 mV is consistent with previous studies showing that PO is voltage-dependent8,27. The shape of the
rTRPV2 ramp I-V relation (Fig. 1C) is thus attributed to voltage-dependent gating rather than pore
rectification.
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RuR functions as a voltage-dependent pore blocker in a number of different TRP channels27, but RuR also
has activity at other targets, including ICRAC/Orai channels and IP3 receptors39. Here we show that RuR (10
M) fully blocks both Itail and inward currents elicited by voltage ramps when co-applied together with 2APB (Fig 1C). Consistent with previous reports27, we find that concentration of extracellularly applied RuR
which is sufficient to block inward current does not completely block outward currents at a (Fig 1C). Our
data are therefore consistent with the hypothesis that RuR functions as a pore blocker in TRPV2 rather than
as a gating modifier or antagonist, and the mechanism of action of RuR is thus distinct from 2-APB and
other gating-modifier agonists and antagonists. We explore this phenomenon again later (Fig. 2B).
Activation of TRPV channels by chemical agonists is slow relative to the rates of voltage-dependent
channel opening. Here we show that, as in previous studies, activation of rTRPV2 by 2-APB is relatively
slow: under our recording conditions, superfusion of 2-APB (500 M) for ~20 s is necessary to achieve
apparent steady-state (Fig 1D). In contrast, apparent steady-state is reached within 100 ms after
depolarization of cells expressing native (Fig. 33) or expressed TRPV2 channels (data not shown). The
apparent rate of pharmacological activation by extracellularly applied 2-APB may depend on perfusion
speed and/or availability of the drug to its binding site(s), which has not been unambiguously identified.
We find that RuR (10 M), which potently blocks TRPV channels 27, rapidly blocks inward TRPV2 current,
arguing that superfusion speed under our experimental conditions is substantially faster than the rate of 2APB current activation. The slow rate of TRPV2 current activation observed here and elsewhere is,
therefore, consistent with the hypothesis that the 2-APB binding site is intracellular, and TRPV2 activation
is temporally delayed by diffusion across the plasma membrane.
Among TRP channels, probenecid (PBC) is reported to selectively agonize TRPV247, however, PBC also
acts at other molecular targets, including organic cation transporters. Here we show that superfusion of
PBC (4 mM) elicits robust currents with an outwardly-rectifying I-V relation similar to 2-APB in cells
expressing TRPV2 (Fig. 2A). Prolonged exposure to agonists such as 2-APB and PBC (4 mM) occasionally
alters the shape of the I-V relation, which becomes linear after agonist superfusion (Fig. 2B). Our data
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suggest that prolonged PBC exposure eliminates voltage-dependent gating in TRPV2. Previous reports
showing that the duration of agonist exposure alters voltage-dependent gating in related TRPV1 and TRPV3
channels25,98,99. One possible explanation for the difference in current rectification is time dependent pore
dilation, which has described for TRPV1 and TRPV325,98,99. However, PI(4,5)P2-dependence also appears
to explain the conversion from voltage-dependent to voltage-independent gating in TRPV348. One
disadvantage to the use of PBC is its low potency, which could be a confounding factor in understanding
its ability to modulate voltage-dependent gating. We have not explicitly tested whether ionic selectivity is
altered in TRPV2 channels that exhibit voltage-dependent vs. voltage-dependent gating, and additional
future experiments are therefore necessary to address the mechanism(s) by which agonists modulate TRPV
channel gating and ion permeation.
As we observed previously when TRPV2 channels are activated by 2-APB, we find that RuR blocks a larger
fraction of inward vs. outward PBC induced current (Fig 2A), indicating that the presumed mechanism of
RuR action (voltage-dependent pore block) is likely to be similar. The anti-allergic drug tranilast (Rizuben)
was previously reported to selectively inhibit TRPV2 channels46,53, and here we show that tranilast (100
M) completely antagonizes both inward and outward currents elicited by PBC (Fig. 2B). The data indicate
that tranilast is likely to operate by a different mechanism from RuR, and we hypothesize that tranilast may
act as a competitive antagonist rather than a pore blocker of TRPV2. Additional studies are needed to clarify
the mechanism of tranilast action at TRPV2 and to identify amino acid residues that form the tranilast
binding site.
Previous reports show that TRPV1-3 channels are non-selectively activated by both psychoactive (i.e., 9THC) and non-psychoactive (i.e., cannabidiol, CBD) phytocannabinoids in the micromolar concentration
range44,97. Here we show here that TRPV2 is activated by CBD (300 M), and that the outwardly-rectifying
shape of the I-V relation is similar to short duration exposure of 2-APB or PBC (Fig. 2C). Although the
cannabinoid binding site in TRPV is not known, mutagenesis and structural studies in TRPV1 and TRPV2
suggest that vanilloids (i.e., capsaicin and resiniferatoxin) share a common site that resides within the S126

S4 ‘vestigial voltage sensor’ domain43. Because cannabinoids and vanilloids act as chemical agonists and
are structurally similar, they may share common binding site, but additional studies are needed to
specifically test this hypothesis. In summary, 2-APB, PBC, and CBD function as pharmacological
activators (agonists) of TRPV2 that modulate voltage-dependent gating. Whereas 2-APB and CBD are nonselective TRPV1-3 agonists, PBC appears to be selective for TRPV247. RuR behaves as voltage-dependent
pore blocker and tranilast’s action is consistent with activity as a competitive antagonist46,53-55. These
compounds establish a limited, but useful, pharmacopeia for selective activation and inhibition of TRPV2
channels.

2. TRPV2 channel is functionally expressed in microglia
TRPV2 channels are important in regulating phagocytes activities64,66,68. They are large conductance cation
channels able to regulate calcium homeostasis in phagocytes68. Specifically, TRPV2 has been shown to
regulate chemotaxis and cytokine production in macrophages66,68. However, TRPV channel functional
expression in microglia is not well examined. To better understand TRP channel functional expression,
immunocytochemistry and western blotting were used to determine TRP proteins, and whole cell voltage
clamp is used to determine the presence of TRP current.
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Figure 3: Immunocytochemical analysis of TRP channel in BV-2 microglia like cells.
BV-2 cells are fixed and incubated with A. rabbit-anti-mouse TRPV2 antibody (1:1000 dilution), B. rabbit-antihuman TRPV3 antibody (1:500 dilution), and C. mouse-anti-TRPA1 antibody (1:1000 dilution). Presence of
TRPV2 (A) and TRPA1 channel proteins (C) are visualized by red immunofluorescence while TRPV3 channel
protein is not detected (B). Positive control of TRPV2 and TRPV3 protein expression are prepared by
transfecting D. EGFP tagged TRPV2 or E. EGFP tagged TRPV3 into HEK-293, and those cells are subjected to
immunocytochemistry to rabbit-anti-mouse TRPV2 antibody (D. 1:1000 dilution) and rabbit-anti-human TRPV3
antibody (E. 1:500 dilution). The green fluorescence shows the presence of EGFP protein and successful
transfection. The localization of EGFP is co-localized with red immunofluorescence indicating TRPV2 and
TRPV3 antibody successfully recognizing transfected HEK-293 cells.

BV-2 cells are fixed, permeabilized, and then subjected to immunocytochemistry (see method 4).
Expression of TRPV2 channel protein was confirmed by antibody recognition of TRPV2 protein in
immunocytochemistry (Fig 3A. red immunofluorescence). On the other hand, TRPV3 channel proteins
were not detected (Fig 3B). To examine whether hTRPV3 antibody are able to recognize TRPV3 protein,
EGFP tagged-hTRPV3 transfected HEK-293 cells were subjected to immunocytochemistry as a positive
control. Cells with successful transfection show green fluorescence, which was co-localized with red
immunofluorescence indicating TRPV3 antibody binding (Fig 3E). TRPV3 antibody are able to detect
hTRPV3 protein in transfected HEK-293 cells (Fig 28E). EGFP-tagged rTRPV2 transfected HEK-293 cells
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Figure 4: Functional expression of TRP channel in BV-2 microglia like cells.
Cultured BV-2 cells are subjected to total cell lysate and subjected to western blotting (see Method 5).
Proteins of total cell lysate separated by 10% SDS-PAGE and blotted by Lane A. rabbit-anti-mouse TRPV2
antibody (1:1000 dilution), Lane B. rabbit-anti-human TRPV3 antibody (1:500 dilution), and Lane C.
mouse-anti-TRPA1 antibody (1:1000 dilution). Lane A. TRPV2 protein band is visualized about 90kDa.
The size of protein band matches with expected size of TRPV2 protein, confirming presence of TRPV2
protein in BV-2 cells. Lane B. No TRPV3 channel protein is detected at expected band of proximately
90kDa. Lane C. TRPA1 protein band is detected approximately 90kDa, size of the protein band matches
with expected size of TRPA1. β–actin visualized by mouse-anti-Actin antibody (1:1000 dilution) is used as
positive control. β–actin protein are present in all lanes at expected protein band size of 42kDa, confirming
protein is loaded into and separated successfully by SDS-PAGE.

are used as positive control for the rTRPV2 antibody. The result shows red immunofluorescence of rTRPV2
antibody binding were co-localized with green fluorescence, indicating TRPV2 antibody is able to
recognize its target (Fig 3D).

TRPA1 proteins are also detected in BV-2 microglia (Fig 3C, red

immunofluorescence). Those results show that TRPV2 and TRPA1 protein is expressed in BV-2 microglia
like cells, but TRPV3 protein is not detected. It is possible that TRPV3 are expressed in low concentration,
but current data suggest that BV-2 microglia like cells mainly express TRPV2 and TRPA1. To confirm
protein expression, western blotting were used to determine the presence of selected TRP protein. Cultured
BV-2 cells are subjected to SDS-PAGE and blotted against TRPV2, TRPV3, and TRPA1 antibody (see
Method 5). Protein band was detected around 80-90kDa by the TRPV2 antibody, indicating the presence
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Figure 5: Functional expression of TRP channel in BV-2 microglia-like cells.
BV-2 cells are subjected to whole cell voltage clamp electrophysiology while TRPV channel agonist and
antagonists are applied. A voltage ramp from -80 mV to +80 mV is repeatedly delivered to the cell to elicit
currents, and the current result is plotted as I-V curve. A. Application of 2 mM 2-APB induces a robust outward
rectified current in BV-2 cells which can be blocked by 10 μM RuR. B. However, application of TRPV1
antagonist 10 μM CZP did not fully inhibit the 2-APB current. C. Similarly, application of up to 10 μM CAP
did not elicit any current, suggesting the current is not TRPV1 mediated. D. TRPV2 channel selective agonist
4 mM PBC induces outward rectified current which can be blocked by 10 μM RuR, and E. TRPV2 channel
selective antagonist 1 μM Tranilast are able to inhibit 1mM 2-APB induced current in BV-2 cells. This
suggests BV-2 contains functional TRPV2 channel. F. 20 μM AITC did not elicit any current, indicating no
TRPA1 functional expression.

of TRPV2 protein (Fig 4A). The TRPV2 protein band size is matched with the reported size of TRPV2.
Consistent with immunocytochemistry, TRPV3 protein is not detected (Fig 4B). TRPA1 protein is expected
to have approximately 90kDa. TRPA1 protein bond was found approximately 80-90kDa (Fig 4C);
conforming TRPA1 protein expression. The anti-β-actin antibody is used to visualize β-action protein for
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loading control. The β-actin protein is detected in all experiments, confirming the lack of the TRPV3 protein
band was not due to low protein loading (Fig 4 A-C).
The presence of proteins does not indicate the formation of functional channels in BV-2 microglia like cells.
For example, TRPV1 channel is known to be expressed in the microglia, but no capsaicin current have been
reported61,102. Whole cell voltage clamp electrophysiology was used to determine functional expression of
selected TRP channels. Under control condition, only leak current was observed in BV-2 cells (Fig 5A-E,
black line). A non-selective TRPV channel agonist 2 mM 2-APB elicit inward rectified current in BV-2
microglia like cells (Fig 5A, green line), which can be blocked by calcium channel blocker 10 μM RuR
(Fig 5A, magenta line). This suggests the presence of TRPV1, TRPV2 or TRPV3 channel in BV-2 cells27.
2-APB induced current was not fully inhibited by TRPV1 channel selective antagonist 10 μM capsazepine
(CZP), indicating the 2-APB current is not carried by TRPV1 (Fig 5B). As expected from published
literature, up to 10 μM TRPV1 selective agonist capsaicin did not elicit an observable current in BV-2 (Fig
5C), confirming 2-APB current is not mediated by TRPV1. TRPV2 channel selective agonist 4 mM PBC
induced outward rectified current similar to TRPV2 (Fig 5D, green line) which is blocked by 10 μM RuR
(Fig 5D, magenta line). Furthermore, 1 mM 2-APB induced current (Fig 5E, green line) is inhibited by coapplication of 1 mM 2-APB and 1 μM Tranilast (Fig 5E, magenta line). Those results indicate the functional
expression of TRPV2 channel in BV-2 microglia. Lastly TRPA1 channel selective agonist 20 μM AITC
did not induce currents in BV-2 (Fig 5F, green line). This result suggests a lack of functional expression of
TRPA1 channel despite the presence of TRPA1 proteins. Together, whole cell voltage clamp indicates that
TRPV2 but not TRPV1 or TRPA1 functionally expressed in BV-2 microglia like cells, and the TRPV2 is
the main conductor of 2-APB induced currents.
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Figure 6: TRPV2 and TRPA1 channel expression in dissociated neonatal mouse primary microglia
enriched culture.
Dissociated mouse neonatal primary microglia cells are fixed and incubated with A. rabbit-anti-mouse TRPV2
channel antibody (1:1000) and B. mouse-anti-TRPA1 channel antibody (1:1000). Red immunofluorescence
indicate presence of TRPV2 (A) and TRPA1 (B) protein. C. Negative control where no primary antibody are
applied. No background staining is detected in (C).

To confirm expression of TRPV2 and TRPA1 channel in native microglia, enriched microglia culture of
neonatal mice is subjected to immunocytochemistry and whole cell electrophysiology. TRPV2 channel
protein is shown to be present in mice neonatal enriched primary microglia culture (Fig 6A, red
fluorescence). Also immunocytochemistry shows TRPA1 channel protein is expressed in mice neonatal
enriched primary microglia (Fig 6B, red fluorescence). The red immunofluorescence is not due to none
specific binding of secondary antibody since no red immunofluorescence is found in no primary antibody
negative control (Fig 6C). Those result confirms TRPV2 and TRPA1 protein in dissociated neonatal mice
primary microglia.
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Figure 7: Functional expression of TRP channel in dissociated neonatal mouse primary microglia
enriched culture.
Enriched mouse neonatal primary microglia cells are subjected to whole cell voltage clamp electrophysiology.
A. Application of 1mM 2-APB induces a robust outward rectified current in BV-2 cell indicating the presence
of TRPV1, TRPV2 or TRPV3 channel. B. Application of TRPV1 channel agonist 100 μM CAP did not induce
a current response, suggesting the 2-APB current is not mediated by TRPV1. C. Application of TRPA1 channel
agonist 20 μM AITC did not elicit any current suggesting that TRPA1 channel is not functionally expressed in
dissociated mouse neonatal primary microglia.

To confirm functional expression of TRPV2 and TRPA1, dissociated neonatal mice primary microglia is
subjected to whole cell voltage clamp. Voltage ramp protocol from -80 mV to +80 mV (1 s duration) is
repeatedly delivered to the cell in the absence and presence of pharmacological agents applied by bath
superfusion. Only small leak current is found under control condition (Fig 7A-C, black line). Application
of 1 mM 2APB induces a rectified current in dissociated mice neonatal primary microglia (Fig 7A). This
result indicates presence TRPV1 or TRPV2 channel in dissociated neonatal mice primary microglia 27.
However, TRPV1 channel selective agonist 100 μM CAP did not elicit current in mice neonatal primary
microglia (Fig 7B). Also TRPA1 selective agonist 20 μM AITC did not induce current despite TRPA1
channel protein is detected (Fig 7C). This result suggests that the TRPA1 channel protein in microglia is
not functional. From those results, it is suggested that TRPV2 channels are main TRPV channels mediate
2APB induced cation currents in microglia since TRPV3 channel protein is not detected and TRPV1 and
TRPA1 channel agonist do not elicit current in microglia despite their protein are expressed.
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Figure 8: Pre-incubation of LPS alters TRPV2 gating in BV-2 cells.
The effect of LPS induction on TRPV2 gating is examined by whole cell voltage clamp. The tail current is
measured during application of 1 mM 2-APB. A. A voltage step from -80mV to 120mV to measure the current
response. Following voltage step, the membrane is stepped to -80mV to measure the instantaneous Itail. B. 2APB elicited BV-2 current response to voltage steps (A) is collected. The instantaneous Itail is analyzed by fitting
the current to an exponential decay function (equation 2). C. The tail current (Y axis) is plotted in relation to
voltage step (X-axis). As membrane step increases Itail become larger and the maximum current is reached about
70 mV. Because instantaneous Itail informs the NPo of the channel, TRPV2 is thought to be activate starting -30
mV and reaching its maximum NPo at +70 mV. D. The instantaneous Itail is then fitted to Boltzmann equation
and normalized. The result is then plotted in Normalized Itail – V plot. The result shows changes of tail current
and apparent Po in response to changes in membrane voltage. Pre-incubation of BV-2 with 2 μg/ml of E.coli
LPS for 30 minutes induced left shift of normalized Itail – V curve compared to control media treated BV-2 cells.

To summarize TRPV2 and TRPA1 protein is present in both BV-2 microglia like cells and dissociated
neonatal mice primary microglia. On the other hand, TRPV3 is not detected in BV-2. Of those channels,
TRPV1 and TRPA1 currents are not found in BV-2 and dissociated neonatal mice primary microglia;
making TRPV2 the main conducting channel for 2-APB induced currents.
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3. LPS pre-administration enhances TRPV2 current in BV-2 microglia like cells.
Our studies have demonstrated that TRPV2 is the mediator of the 2-APB induced current in BV-2. Elevated
H2O2 concentration is commonly observed in activated microglia and macrophages75,76,103. Administration
of LPS is known to induce production of cytokine and phagocytosis in macrophage that is mediated by
TRPV2. However, whether and how LPS activate TRPV2 is not known. LPS, a gram-negative bacteria
outer wall glycoprotein, is commonly used in microglia research as a pro-inflammatory stimulation75,76.
LPS application to microglia is known to induce production of H2O2 and cause pro-inflammatory activation
of microglia. Given results in macrophage, LPS is likely to activate TRPV2. To test the hypothesis of
activated microglia have enhanced TRPV2 activity, BV-2 cells are treated with control media or with 2
g/ml of E.coli LPS for 30 minutes and then subjected to whole cell voltage clamp electrophysiology.

A voltage step from -80 mV to 120mV is applied to BV-2 to elicit the steady state current response at
different voltages. Following voltage step, -80 mV membrane step is applied to measure the Itail response
(Fig 8A). Note that steady state current is archived during 500 ms of voltage step (Fig 8B). Following
voltage step, -80 mV membrane step induced an instantaneous tail current of different size (Fig 8B). The
instantaneous tail current is then analyzed for its relation to voltage step, time of decay, and maximum
size (see method 7c). A representative tail current response plotted against voltage step is shown in Fig
33C. Tail current remains low during -80 to -20 mV membrane step, and gradually increase over -20 mV
to 70 mV membrane step; reaching maximum tail current during -70 mV to 120 mV (Fig 8C). The tail
current is directly proportional to the NPo, thus results indicate TRPV2 channel is opened over -20 to 70
mV membrane step and reaching maximum NPo at 70 mV. The Itail-V curve is fitted to Boltzmann
equation (equation 3) and normalized for analysis of half maximum Po (V0.5), valance charge (z) and size
of tail current. Normalized tail current – voltage curve (Normalized Itail-V) is constructed (Fig 8D). Note
that 30 minutes pretreatment of 2 μg LPS shifted the normalized Itail-V curve to the left (Fig 8D). In
media pre-treated BV-2 cells, 1 mM 2-ABP increased apparent NPo starting -40mV, and apparent NPo
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Figure 9: Analysis of LPS effect on TRPV2 gating in BV-2 cells.
Tail current of media treated and 2 μg/ml LPS treated BV-2 cells are analyzed. Cultured BV-2 cells are treated
with no-LPS containing media or 2 μg/ml LPS containing media for 30 minutes in 37ᵒC, and subjected to
whole cell voltage clamp. A. Half maximum open probability (V0.5) is calculated by measuring membrane
voltage required to elicit 50% of maximum voltage under 1 mM 2-APB condition in BV-2 cells. In control
media treated cells 14.7 ± 6.7 mV (n = 7) is required to reach V0.5 compared to -12.7 ± 2.7 mV (n = 6) required
for V0.5 in 2 μg/ml LPS pretreated BV-2 cells. The result shows a statistically significant reduction of V0.5 in
cell pretreated by 2 μg/ml LPS (p = 0.004). B. The slope factor (dx) are determined by fitting normalized tail
current to voltage curve to Boltzmann equation (equation 3). In control media treated cells dx is 18.3 ± 2.0
C/(J*mol, n = 7), and dx is 20.8 ± 4.6 C/(J*mol) in BV-2 cells pretreated with 2 μg/ml LPS (n = 6). No
statistically significant difference is found between two groups (p = 0.61). C. Itail current is determined by
subtracting baseline current (minimum tail current) from the maximum tail current. The tail current is 0.6 ±
0.1 nA under control condition (n = 7) and 0.6 ± 0.1 nA in 2 μg/ml LPS pretreated condition (n = 6). No
statistically significant difference is the found (p = 0.52). D. ITAIL decay time (τ) is measured by fitting
instantaneous Itail following +80 to +120 mV step to exponential decay function (equation 2). Tail current
decay time is 76.3 ± 13.8 ms (n = 7) under control condition, and tail current decay time is 203.7 ± 35.8 ms (n
= 5) in 2 μg/ml LPS pretreated BV-2. Tail current decay time in 2 μg/ml LPS pretreated BV-2 is significantly
increased compared to control media treated BV-2 cells (p = 0.003). Statics is analyzed by student t-test and
results are considered significantly different if α<0.05.

reached the maximum around 70 mV (Fig 8D, black line). In 2 μM LPS pre-treated BV-2 cells, 1 mM 2ABP increased apparent NPo starting -50 mV, and apparent NPo reached the maximum around 30 mV
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(Fig 8D, green line). The V0.5 in media treated BV-2 cells are 13.1 ± 1.5 mV while V0.5 in 2μg/ml LPS
pre-treated BV-2 cells are -14.8 ± 1.3mV. This result suggests that the TRPV2 channel is more easily
activated following LPS stimulation.
Statistical analysis shows that V0.5 is significantly different between control media treated BV-2 cells and
2 μg/ml LPS treated BV-2 cells (p = 0.004, Fig 9A). V0.5 in control media treated cells are 14.7 ± 6.7 mV
(n = 7) and V0.5 in 2 μg/ml LPS pretreated BV-2 cells -12.7 ± 2.7 mV (n = 6, Fig 9A). This result indicates
TRPV2 require less membrane depolarization to be activated if BV-2 microglia like cells is pre-treated with
LPS. The slope factor (dx), did not change between control media pre-treated and LPS pre-treated BV-2
cells (p = 0.61, Fig 9B). In control media treated cells dx is 18.3 ± 2.0 C/ (J*mol, n = 7), and dx is 20.8 ±
4.6 C/ (J*mol) in 2 μg/ml LPS pre-treated BV-2 cells (n = 6, Fig 9B). Also, the size of tail current did not
change between two groups (p = 0.52, Fig 9C). The tail current is 0.56 ± 0.08 nA in control media pretreated cells (n = 7) and 0.6 ± 0.1 nA in 2μg/ml LPS pretreated BV-2 cells (n = 6). This result indicates that
despite the shift in V0.5, the maximum NPo of TRPV2 does not change if the membrane is fully depolarized.
Finally, tail current decay time (τ) is measured by fitting +80 to +120mV step induced tail current to
exponential decay function (equation 2). The tail current decay time is 76.3 ± 13.8 ms (n = 7) in control
media pre-treated BV-2 cells and 203.7 ± 35.8 ms (n = 5) in 2 μg/ml LPS pretreated BV-2. The tail current
decay time in 2 μg/ml LPS pretreated BV-2 is significantly increased compared to control media treated
BV-2 cells (p = 0.003). This result indicates that TRPV2 favors open state more if BV-2 cells are pre-treated
with LPS.
Our results indicate that LPS stimulation of BV-2 microglia-like cells make TRPV2 open at a more negative
membrane potential and make TRPV2 close slower once they are activated. In turn, those results imply that
TRPV2 become easier to open in pro-inflammatory activated microglia, and TRPV2 channel will have
enhanced activity when microglia is activated.
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4. TRPV2 single channel properties
Although macroscopic whole-cell currents yield valuable information about TRPV2 biophysical properties,
determining additional discriminative properties (i.e., single channel conductance, ) requires additional
experimental techniques. Classical ion channel theory hypothesizes that macroscopic currents (I) are
proportional to the product of the number of functional channels in the cell membrane (N), the amplitude
of unitary current (i), and PO (see Method 7f, equation 6):
𝐼 = 𝑁 ∙ 𝑖 ∙ 𝑃𝑂𝑃𝐸𝑁 .
Unitary current (i) is proportional to unitary conductance () by the driving force, which depends on
membrane potential (VM) and the ‘reversal’ potential (EREV) of current flowing through the open channel
by (see Method 7e, equation 5):
𝑖 = 𝛾 ∙ (𝑉𝑀 − 𝐸𝑅𝐸𝑉 )
Despite its potential utility in discriminating between otherwise biophysically similar channels, the single
channel conductance of TRPV2 has not previously been reported35,43,70,104. Furthermore, it is not known
whether different channel agonists alter  in TRPV2. We, therefore, sought to measure TRPV2 unitary
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Figure 10: 2-APB elicits single TRPV2 channel activity in excised membrane patches.
Excised inside-out patches were pulled from HEK-293 cells expressing GFP-rTRPV2 and subjected to voltage
clamp (Methods). A, B. Currents recorded at 5 different time intervals in a representative patch at -80mV (A)
or +80 mV (B) under control conditions are shown. Note that no channel openings are observed. C, D.
Addition of 2-APB (50 μM) to the bath solution (i.e., cytosolic face of the patch) elicits channel activity at
both -80 mV (C) and +80 mV (D). Red box shows enlarged view of single channel activity across 200 ms. In
A-D, dashed lines indicate the leak-subtracted zero current amplitude, which corresponds to the closed channel
state (c). E, F. All-points histograms of the data shown in panels A-D in the absence (control, black circles)
and presence (green circles) of 2-APB (50 μM) measured at +80 mV (E) or -80 mV (F) are shown. Lines
represent fits of the data to the sum of several Gaussian functions (see Methods); the positions of peaks
determined from Gaussian fits are used to determine unitary current amplitude (-7.7 pA at -80 mV and 5.3 pA
at +80 mV, magenta lines). Insets show expanded views of the data in panels E and F. Patches in which
several channels are simultaneously open generate addition peaks with amplitudes that are approximately
multiples of the first peak (-16.0 pA at -80mV, cyan line). Current noise and the possible existence of subconductance states preclude unambiguous determination of additional open-state current amplitudes at +80
mV.

current amplitudes in inside-out patches excised from HEK-293 cells expressing rTRPV2. Such
measurements could also be useful for directly determining Po under defined experimental conditions.
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Consistent with a previous report, we find that TRPV2 exhibits a low open probability when no agonist is
present 43: no channel openings are observed in 5 representative recordings at either +80 mV or -80 mV
(Fig. 10A, B). Gaussian fits of all-points histograms of excised patch currents measured over a total of 18
s at either -80mV membrane step or +80mV yield a single large peak centered at ~0 pA corresponding to
the closed-channel state (Fig. 10E, F). Our excised patch data is consistent with whole-cell recording, where
membrane depolarization alone was insufficient to elicit measurable TRPV2 current (Fig. 1). The apparent
voltage-insensitivity of TRPV2 in the absence of agonist contrasts with the behavior of expressed rTRPV1
and hTRPV3 channels, for which depolarization alone is sufficient to cause channels to open (Figs. 6A and
8A).
Superfusion of 2-APB (50 μM) in the bath solution (i.e., to the cytosolic face of the membrane and
intracellular side of the channel) induces a marked increase in TRPV2 channel activity, and channel
openings are detected at both -80mV and +80mV (Fig 10C, D). In contrast to TRPV1 (Fig. 6) and hTRPV3
(Fig. 9), TRPV2 current records are characterized by ‘erratic’ TRPV2 channel activity (Fig 10C, 10D).
TRPV2 channels under our recording conditions are characterized by brief openings and appear to manifest
sub-conductance states (Figs. 10C and 10D, 11D, 15B, and 15C). Previous studies report similar ‘erratic’
gating phenomena and sub-conductance states in a mutant TRPV2 channel35,43, but single channel currents
in WT TRPV2 were not measured. All-points histograms generated from our excised patch data indicate
the existence of two or more main open channels (i ≈ -8 pA at -80 mV; Fig. 10E). Broad Gaussian fits to
the main open states suggest the possibility that we also measure other, more rarely populated subconductance states (Fig 10E, 10F). Additional peaks are fitted to Gaussian curve and their location to closed
channel peak is measured to estimate unitary current of TRPV2 (see method 7e). The potential existence of
sub-conductance states could interfere with our ability to resolve the main vs. sub-conductance unitary
TRPV2 current amplitudes, particularly at voltages where apparent Po is higher (i.e., +80mV). The unitary
current amplitude estimated from the peak of a Gaussian fit to the data (5.3 pA; Fig. 10F) is smaller than
expected based on our estimate of i at -80 mV. In summary, TRPV2 channels exhibit rapid gating and sub-
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Figure 11: CBD elicits single TRPV2 channel activity in excised membrane patches.
Excised inside-out patches were pulled from HEK-293 cells expressing GFP-rTRPV2 and subjected to
voltage clamp at -80mV or +80mV. A, B. No channel openings are observed at 5 different time intervals in
a representative patch at -80mV (A) or +80 mV (B) under control conditions. C, D. Addition of CBD (300
μM) to the cytosolic face of the patch elicits channel activity at both -80 mV (C) and +80 mV (D). In A-D,
leak-subtracted closed-channel (c) amplitudes are presented are indicated by dashed lines. Red box shows
enlarged view of single channel activity across 200 ms. E, F. All-points histograms of the data shown in
panels A-D in the absence (control, black circles) and presence (green circles) of CBD measured at +80
mV (E) or -80 mV (F). Lines represent fits of the data to the sum of three Gaussians (only fits to openchannel amplitude histograms are shown). Insets shows expanded views of the data in panels E and F.
Unitary current amplitudes of CBD activated channels determined from Gaussian fits are -8.1 pA (E: -80
mV, magenta line) and 6.0 pA (F: +80 mV, magenta line). Gaussian fits to second peaks (cyan lines in E
and F) have amplitudes that are approximately double the size of the first peak (magenta lines).

conductance states that make it difficult to unambiguously determine the amplitude of the single channel
current. Nonetheless, we estimate that the main conducting state of rTRPV2 is likely to be ~ -8 pA at -80
mV, which is consistent with a previous report43. We revisit this interpretation in subsequent experiments.

41

Figure 12: Unitary currents and conductance of TRPV2 at +80 mV and -80 mV.
Gaussian fits of all-points histograms were used to determine unitary current amplitudes (i) and unitary
conductance () is calculated ( = i/(V – EREV)). A. Mean 2-APB (concentration?) activated unitary
TRPV2 current amplitudes are -8.32 pA at -80mV and 8.24 pA at +80mV (n = 7 patches each). B.
Mean CBD (concentration?) activated unitary TRPV2 current amplitudes are 8.3 pA at -80mV and 8.4
pA at +80mV (n = 4 patches each). C. Mean unitary conductance of 2-APB activated TRPV2 are 103.8
pS at -80 mV and 93.5 pS at +80 mV (n = 7 patches each). D. CBD activated TRPV2 channels exhibit
unitary conductance of 104.3 pS at -80mV and 105.4 pS at +80 mV (n = 4 patches each). Differences
in unitary conductance at -80mV vs. +80mV step and in presence of 2-APB vs. do not reach statistical
significance (p > 0.05 by Student’s unpaired t-test).

Similar to 2-APB, CBD (300 M) activates TRPV2 channel activity in inside-out patches (Fig. 11). CBD
appears to cause TRPV2 channels to open only briefly (flicker) like 2-APB (Fig 11C, 11D). All-points
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Figure 13: 2-APB induced TRPV1 single channel currents in excised membrane patches.
Excised inside-out patches were pulled from HEK-293 cells expressing GFP-rTRPV1 and subjected to
voltage clamp at +80mV. A. 5 different time intervals in a representative patch in control conditions are
shown; unlike TRPV2, occasional TRPV1 channel openings are observed +80mV in the absence of 2-APB.
B. Addition of 2-APB (50 μM) to the cytosolic face of the patch elicits an increase in TRPV1 channel activity
observed over 5 different time intervals. In A and B, leak-subtracted closed-channel (c) amplitudes are
presented are indicated by dashed lines. Red box shows enlarged view of single channel activity across 200
ms. C. All-points histograms of the data shown in panels A and B in the absence (control, black circles) and
presence (green circles) of 2-APB (50 μM) are shown. D. An expanded view of the data in panel C is shown.
Gaussians fits to open-channel histograms yields a unitary current amplitude of 4.8 pA (magenta line); a
second open-channel peak is located at 12.4 pA (cyan line).

histograms of currents measured over 18 s in a representative patch are more clearly fit Gaussian functions
with peaks at -8.1 pA (-80 mV, Fig 11E) and 5.9 pA (-80 mV, Fig 11F).
Experiments conducted in a number of different patches allow us to estimate 2-APB and CBD activated
TRPV2 single channel current amplitudes at +80 mV and -80 mV (Fig. 12A, 12B). Fig. 12A shows that the
mean 2-APB activated unitary current amplitude at +80 mV (8.2 ± 1.6 pA) vs. -80mV (i = -8.3 ± 1.1 pA)
is not different (p = 0.87 by Student’s unpaired t-test). Similarly, no difference between mean CBD induced
unitary current at -80 mV (-8.3 ± 1.2pA) vs. +80 mV (8.4 ± 1.4 pA) is observed (Fig. 12B). Our results
compare well to the estimated unitary conductance in the rTRPV2 quadruple (F472S, L507M, S510T,
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Q530E) mutant, for which  = 101 pS43. Unitary TRPV2 conductance calculated from our data (Fig. 12C)
reveal no significant difference (p = 0.87) between 2-APB activated  measured at -80 mV ( = 103.8 ±
18.9 pS) vs. +80 mV ( = 93.5 ± 24.1 pS). Unitary conductance in CBD activated TRPV2 channels are also
the same at -80mV ( = 104.3 ± 14.4 pS) and +80 mV ( = 105.4 ± 17.7pS; p = 0.96) and not different (p =
0.99) from 2-APB activated channels (Fig. 12C, D). Although macroscopic TRPV2 currents exhibit
outward rectification (Figs. 1, 2), it was not previously clear whether the differences in inward vs. outward
current amplitudes were caused by differences in gating (i.e., Po) or intrinsic pore rectification27. Our results
in excised patches (Fig. 12) indicate that macroscopic current rectification in TRPV2 is attributable to
voltage-dependent gating.
Unlike TRPV2, the single channel activity of TRPV1 and TRPV3 does not exhibit ‘erratic’ behavior. Under
control conditions and at +80 mV, TRPV1 channels open occasionally, TRPV1 channel openings are rarely
observed, indicating that apparent N·Po is low (Fig. 13A, C). Bath superfusion of 2-APB (50μM) increases
channel activity (Fig 13B), and an all-points histogram assembled from a representative patch recording
shows that 2-APB induced TRPV1 single channel has a current amplitude of ~5 pA (+80 mV; Fig 13C).
The mean unitary conductance measured in several patches pulled from cells expressing rTRPV1 is 81.0 ±
14.3 pS at +80 mV (Fig. 14). In contrast to TRPV1 and TRPV2, TRPV3 is reported to mediate large unitary
currents ( = 185 – 206 pS, depending on cell type)9,48,105. 2-APB (10 μM) elicits channel activity (Fig 16B)
in patches pulled from HEK-293 cells expressing hTRPV3 and a Gaussian fit to the representative all-points
histogram (i = 14.3 pA;  =175.3 ± 16.5 pS; Figs. 14, 16) yields a similar value to previously reports9,48,105.
TRPV1 and TRPV3 (Figs. 13, 16) also exhibit ‘well-behaved’ single channel activity with open times that
are sufficiently long to allow for unambiguously determination of single channel currents from visual
inspection of our experimental data, consistent with previous reports 48,105-107.
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Figure 14: Comparison of unitary conductance in TRPV1, TRPV2 and TRPV3.
Unitary currents for TRPV1, TRPV2 and TRPV3 channels were determined from currents
measured at +80 mV in inside-out patches excised from HEK-293 cells, as shown in Figs. 6-9
and 12. Mean peak values from Gaussian fits all-points histograms are: TRPV1, 81.0 ± 14.3
pS (n = 3); TRPV2, 93.4 ± 12.0 pS (n = 7); TRPV3, 175.3 ± 16.5 pS (n = 4). * Indicates TRPV3
unitary conductance is significantly different compared to TRPV1 and TRPV2 by one-way
ANOVA with α < 0.05.

The TRPV2 channel unitary conductance estimated here is more similar to TRPV1 (80-100 pS)106,107 than
TRPV3. TRPV1 channel unitary conductance is reported to be and TRPV3 unitary conductance is reported
to be approximately 150 pS48,105, consistent with our results. Our estimate of the TRPV2 unitary
conductance is approximately midway between the value reported for native mechanosensitive currents in
Jurkat cells (~40 pS) and purified, reconstituted TRPV2 channels in proteoliposomes (304 pS)35,70. The
reasons for such discrepancies remain unclear, and additional experiments are needed to determine if
TRPV2 unitary conductance is variable like other TRPV channels and whether differences between
experimental conditions used here and elsewhere account for the variations in the unitary conductance35,43,70.
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Figure 15: 2-APB and DCPIB induced TRPV2 activity in excised membrane patches.
Channel activity is measured in inside-out patches excised from HEK-293 cells expressing EGFP-rTRPV2
at +80 mV as described previously. Leak-subtracted zero current amplitudes are presented with closed
channel state (c) indicated by dashed lines. A. No channel opening is measured under control conditions.
B. Application of 2-APB (200 μM) to the bath solution increases TRPV2 channel activity. C. Application
of DCPIB (10 μM) together with 2-APB (200 μM) further increases TRPV2 channel activity. In A-C, leaksubtracted closed-channel (c) amplitudes are presented are indicated by dashed lines. Red box shows
enlarged view of single channel activity across 200 ms. D. All-points histograms of data in panels A-C are
represented by black circles (control), green circles (2-APB alone) and purple circles (2-APB + DCPIB).
Inset shows an expanded view of the data. Gaussian fits to the open-channel histogram data yield peak
values of 5.83 pA (2-APB alone, magenta line) and 8.04 pA (2-APB + DCPIB, orange line). E. Open
probability of the TRPV2 channel measured by Clampfit single channel detection program shows coapplication of DCPIB significantly increases open probability of TRPV2 channel (NPo = 1.31 ± 0.39, n=3)
compared to application of 2-APB alone (NPo = 0.12 ± 0.02, p = 0.03; n=3). F. Unitary current of TRPV2
channel is significantly increased if DCPIB is co-applied with 2-APB (11.00 ± 1.36 pA, p = 0.04; n=3)
compared to 2-APB alone (6.45 ± 0.79 pA n=3). Unitary current is converted to unitary conductance
(equation 5). Unitary conductance of 2-APB induced TRPV2 current is (80.6 ± 9.9 pS, n=3), and unitary
conductance of TRPV2 is (137.6 ± 17.0 pS, p = 0.04; n=3) if DCPIB is co-applied with 2-APB. Statics is
analyzed by paired student t-test with α<0.05 for significance.
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5. DCPIB alters TRPV2 unitary conductance
Erratic single channel activities of TRPV2 are partially caused by the presence of sub-conductance. Subconductance can be caused either by innate biophysical property of TRPV2 or by the presence of another
channel. HEK-293 cells are known to contain swell activated chloride current, ICl,swell. ICl,swell is mediated
by a stretch and H2O2 activated channel that has a unitary conductance of approximately 10-20 pS108. ICl,swell
would induce 1-2pA current under -80mV or +80mV membrane step and could be responsible to subconductance observed. In order to confirm ICl,swell is not causing sub-conductance, we used the ICl,swell
inhibitor DCPIB. Excised inside-out patch clamp recording of TRPV2 channel shows no channel activity
under control conditions, while superfusion of 200 μM 2-APB induces channel opening of varying unitary
conductance (Fig 15A, 15B). Superfusion of 10 μM DCPIB in addition to 200 μM 2-APB increases TRPV2
activity (Fig 15C). Note that small conductance still presents in the patch after addition of DCPIB (Fig 15C),
suggesting sub-conductance states are an innate biophysical property of TRPV2, and not caused by the
presence of ICl,swell under our recording conditions. Furthermore, 2-APB is found to be an inhibitor of ICl,swell,
as 100 μM of 2-APB inhibited ICl,swell109. These results suggest TRPV2 have more than one open state with
different unitary conductance, or alternatively, modulation of TRPV2 such as phosphorylation or PI(4,5)P2
binding induces a change in TRPV2 unitary conductance18.
Interestingly DCPIB itself may change unitary conductance of TRPV2. Modulation of TRPV2 NPo and
unitary current by DCPIB is confirmed in all point histogram. All point histogram shows that co-application
of 2-APB and DCPIB caused a right shift of open channel peak, as well as increase the size open channel
peak (Fig 15D). This result suggests DCPIB enhances both NPo and unitary current of 2-APB induced
TRPV2 single channel activity. 2-APB induces NPo equal to 0.12 ± 0.02 and unitary conductance of 80.62
± 9.9 pS at +80mV membrane step. Co-application of 2-APB and DCPIB induces NPo equals to 1.31 ±
0.39 and unitary conductance equals to 137.6 ± 17.0 pS at +80mV membrane step (Fig 15E, 15F). DCPIB
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Figure 13: 2-APB and DCPIB induced TRPV3 activity in excised membrane patches.
EGFP-hTRPV3 channel transfected HEK-293 cells are subjected to excised inside-out patch clamp
electrophysiology. Membrane potential is clamped to +80mV and the current response recorded.
Leak-subtracted zero current amplitudes are presented with closed channel state (c) indicated by
dashed lines. A. Low channel opening is detected under control condition in 5 different time intervals
in a representative patch at +80mV. B. Application of 10μM 2-APB to the cytosolic face of the patch
induces increases TRPV3 channel opening. C. Application of 10μM DCPIB in addition to 10μM 2APB further increases channel opening of TRPV3 channel. The red box shows an enlarged view of
single channel activity across 200 ms. D. Data in panel A-C are summarized in all point histogram.
TRPV3 channel opening increased after 2-APB administration (green circle) compared to control state
(black circle). Insets show expanded views of the data in panels D. Gaussian fit is used to determine
unitary current of TRPV3 channel. Unlike TRPV2, the addition of DCPIB did not shift open channel
peaks to right. 2-APB application induced first major peak with 14.31pA current (magenta line), and
second major peak with 29.08pA current (cyan line). Co-application of 2-APB and DCPIB increased
the amplitude of the first peak but does not induce a rightward shift of the first peak (purple circle).
Application of 2-APB plus DCPIB induces single channel opening with the first peak equals to
15.57pA (orange line) and second peak equals to 29.82pA (yellow line). E. Open probability of the
TRPV3 channel is measured by Clampfit single channel detection program. Application of 2-APB
alone induced NPo=0.85 ± 0.26 (n=4). Co-application of 2-APB and DCPIB induces NPo=1.55 ± 0.51
(n=4). No statistically significant difference is found between two groups (p = 0.07). F. Unitary current
and unitary conductance of TRPV3 channel do not change following the addition of DCPIB. 2-APB
induces the unitary current of 14.02 ± 1.52pA while co-application of 2-APB and DCPIB induces the
unitary current of 14.24 ± 1.10pA (n=4). The unitary conductance of 2-APB induced TRPV3 current
is 175.3 ± 16.5 pS and unitary conductance of 2-APB and DCPIB induced current is 178.1 ± 12.0 pS.
No statistical significant difference is found between two groups (p=0.89). Statics is analyzed by
paired student t-test, and results are considered significant if p<0.05.

increases 2-APB induced TRPV2 channel NPo (p = 0.03) and unitary current (p = 0.04) significantly (Fig
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15E, 15F).

Figure 17: Statistical comparison of DCPIB effect on TRPV2 and TRPV3 unitary conductance.
The unitary current of TRPV2 and TRPV3 channels under DCPIB treated condition are measured by the
Gaussian fitting of the all point histogram. The significant difference is found between unitary conductance of
2-APB induced TRPV2 current (80.6 ± 9.9 pS) and TRPV3 current (175.3 ± 16.5 pS). However, no difference
in unitary conductance between co-application of 2-APB and DCPIB induced TRPV2 current (137.6 ± 17.0 pS)
and TRPV3 current (178.1 ± 12.0 pS) is observed. * indicate a significant difference between TRPV3 channel
unitary conductance compared to 2-APB induced TRPV2 unitary conductance. Statistics are measured by oneway ANOVA with the significance of regression coefficient of α<0.05.

Unlike TRPV2, DCPIB did not alter the size TRPV3 channel unitary current. Under control condition
representative current traces shows infrequent channel activity when the membrane voltage is stepped to
+80mV (Fig 16A). Superfusion of 10 μM 2-APB to cytosolic face increases channel activity (Fig 16B),
further superfusion of 10 μM DCPIB in addition to 10 μM 2-APB seems to enhance TRPV3 channel
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activities (Fig 16C). All point histogram confirms DCPIB enhanced TRPV3 channel activity; 2-APB plus
DCPIB have larger first and second open peak (Fig 16D, magenta circle) compared to 2-APB alone (Fig
16D, green circle). However, unlike TRPV2, all point histogram of TRPV3 did not show a right shift of
open channel peak after co-application of 2-APB and DCPIB (Fig 16D). This result suggests DCPIB did
not increase the unitary current of 2-APB induced TRPV3 current. In TRPV3 channel, 2-APB alone induces
NPo equals to 0.84 ± 0.26 and unitary current equals to 175.3 ± 16.5 pS at +80mV step (Fig 16E, 16F). Coapplication of 2-APB and DCPIB induces NPo equals to 1.55 ± 0.51 and unitary current equals to 178.1 ±
12.0 pS at +80mV step (Fig 16E, 16F). DCPIB did not induced significant change in NPo (p=0.07) or
unitary current (p=0.90; Fig 16E, 16F). One-way ANOVA indicates that 2-APB induced TRPV2 unitary
conductance and 2-APB induced TRPV3 unitary conductance was significantly different to each other
(p=0.003; Fig 17). However, co-application of 2-APB and DCPIB induced a larger TRPV2 current which
is no longer significantly different to TRPV3 unitary conductance (Fig 17). The result clearly shows DCPIB
only increases TRPV2 channel NPo and unitary conductance but not that of TRPV3.
Pharmacological reagents are known to modulate TRPV2 Po; both 2-APB and CBD are thought to increase
Po of TRPV2. However, in addition to increasing NPo of TRPV2, DCPIB was able to increase unitary
conductance of TRPV2. This suggests DCPIB alters pore structure of TRPV2. Furthermore, the DCPIB
effect is unique to TRPV2 but not to TRPV3, suggesting DCPIB may interacting or altering structure unique
to TRPV2. DCPIB increases TRPV2 unitary current, essentially making TRPV2 more TRPV3 like.
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Figure 18: proposed residues regulate unitary conductance of TRPV channel.
TRPV have similar pore structure to KcsA. A. KcsA pore structure is shown in ribbon diagram
(structure 1BL8: Doyle et al. 1998). The GYGVT amino acid sequence in the blue box forms the
selectivity filter of pore of the KcsA. Two subunit near by the pore W67 and D80 are thought to
form the ionic interactions that stabilizes pore. B. Structure of TRPV1 is shown in ribbon diagram
(3J5P: Liao et al, 2013). The blue box indicate the GMGD amino acid sequence which forms
selectivity filter of pore of TRPV1 channel. Similar to KcsA, TRPV1 contains two polar subunit
near the pore E648 and K656. E648 and K656 on pore loop can also form electrostatic interactions
that stabilize pore structure. C. Overlay of TRPV1 channel structure (yellow ribbon) and KcsA
structure (pink ribbon) shows structural similarities of two channels. D. structure of TRPV2 is
shown in ribbon diagram (5hi9: Huynh et al.). TRPV2 contains two polar units near pore loop,
E614 and R619. E. Comparison of TRPV1, TRPV2, TRPV3 and KcsA reveals potential
electrostatic interaction of E648, E651 and K656 in TRPV1. However this interaction cannot be
formed in TRPV3. In TRPV3 channel, E648 position is replaced by N643, E651 is replaced with
Q646 and K656 position is replaced by P651. In TRPV2 channel, E648 position is replaced by
A611 but other two charged residues are conserved. E651 is conserved as E614 and a basic amino
acid K656 position is replaced by another basic amino acid R619. This indicate TRPV3 do not
have charged residue at S5-S6 pore loop to stabilize the pore structure. This may be cause of larger
conductance in TRPV3. We hypothesized that lack of this electrostatic interaction may underlies
difference in unitary conductance in TRPV1, TRPV2 and TRPV3 channel.

6. Charged residues in S5-S6 poor loop does not regulate unitary conductance of TRPV channels
The ability of DCPIB modulating TRPV2 unitary conductance suggest TRPV2 poor loop structure can be
potentially altered by pharmacological reagents (Fig 15). This suggests that TRPV2 poor loop structure
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may be flexible than initially expected. TRPV channel is thought to have a similar structure as Kv channels;
they have similar six transmembrane domains, pore loop, and selectivity filter7. KcsA channel, a prokaryotic
potassium channel, have similar pore structure compared to TRPV channels (Fig 18 A-C). Overlay of KcsA
and TRPV1 shows two channel aligns closely in the S5 transmembrane domain, S5-S6 loop and the S6
transmembrane domain (Fig 18C); indicating two channel may have similar pore structure. Modulation of
S5-S6 electrostatic interaction are reported to modulate KcsA gating property; Cordero-Morales reports
that disruption of W67 – D80 hydrogen bonding result in a change of single channel NPo and KcsA
inactivation process (Fig 18A)110. This demonstrates the electrostatic interaction between S5 and S6 loop
can alter channel biophysical property.
Similar electrostatic interaction is conserved in TRPV1 (Fig 18B). In TRPV1 glutamic acid (E651) residue
located in close proximity to lysine (K656) suggesting potential formation electrostatic interaction (Fig
18B). Same electrostatic interaction is conserved in TRPV2. E651 equivalent residue in TRPV1 is
conserved (E614), and negatively charged K656 equivalent residue in TRPV1 is replaced by similarly
charged arginine (R619; Fig 18E). This electrostatic interaction is not present in TRPV3 as E651 equivalent
residue in TRPV1 is replaced by polar glutamine (Q646), and charged K656 equivalent residue in TRPV1
is replaced by hydrophobic proline (P651; Fig 18E). We hypothesized that formation of a potential
interaction between E651 and K656 may configure pore structure in TRPV1 and TRPV2 to a small unitary
conductance state, while the lack of electrostatic interaction may result in large unitary conductance in
TRPV3. To examine this hypothesis, charged R619 residue in TRPV2 is mutated to proline in order to
convert TRPV2 channel to TRPV3 like, and vice versa charged residues are introduced to TRPV3 by
mutation of Q646 residue to glutamic acid and P651 residue to arginine to convert TRPV3 channel to
TRPV2 like.

52

Figure 19: 2-APB induced R619P mutant TRPV2 activities in excised membrane patches.
HEK-293 cell is transfected with the EGFP-R619P-rTRPV2 mutant channel and subjected to excised inside-out
patch clamp electrophysiology. The membrane is then stepped to -80 or +80 mV. Leak-subtracted zero current
amplitudes are presented with closed channel state (c) indicated by dashed lines. A, B. Currents recorded at 5
different time intervals in a representative patch at -80 mV (A) or +80 mV (B) under control conditions are
shown. Note that no channel openings are observed. C, D. Addition of 500 µM 2-APB to the bath (cytosolic
face of the patch) elicits sporadic channel activity at -80 mV (C), while larger channel activity is observed in
+80 mV (D). The red box shows an enlarged view of single channel activity across 200 ms. E, F. All-points
histograms of the data shown in panels A-D in the absence (control, black circles) and presence (green circles)
of 500 μM 2-APB measured at -80 mV (E) or +80 mV (F) are shown. Insets show expanded views of the data
in panels E and F. Lines represent fits of the data to Gaussians; the position of the first major peak is 6.2 pA at
-80 mV (E, magenta line) and 6.9 pA at +80 mV (F, magenta line). G. The unitary conductance is calculated
from the unitary current by the equation 5. Compared to the wild-type rat TRPV2 channel, R619P mutant did
not change unitary conductance. Wild-type TRPV2 channel has unitary conductance of 93.4 ± 12.0 pS (n = 7),
while R619P mutant have 97.4 ± 8.2 pS (n = 4). No statistical difference is observed (p = 0.84). Statics is analyzed
by student t-test with α<0.05 for significance.

The mutagenesis is introduced to TRPV2 and TRPV3 respectively by PCR and cloned into EGFP vector.
The resulting EGFP-R619P-rTRPV2 protein is then expressed in HEK-293 cells and subjected to excised
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inside-out patch clamp electrophysiology. Similar to wild-type TRPV2, no channel activity is observed
under control condition (Fig 19A, 19B). TRPV2 and TRPV3 common activator 2-APB is then superfused
to elicit current27. The addition of 500 μM 2-APB elicit sporadic channel activity when the membrane is
stepped to -80mV, but 500 μM 2-APB elicit robust channel activity when the membrane is stepped to +80
mV (Fig 19C, 19D). Consistently with wild-type channel, larger NPo is observed when the membrane is
stepped to +80 mV, however, the reason for sporadic channel activity in -80 mV is not clear (Fig 19C, 19D).
Note that subconductance is still observed (Fig 19D). Also consistent with the wild-type TRPV2 channel,
the Gaussian fit of all point histogram shows 2-APB induced unitary current is 6.2 pA at -80mV membrane
step and 6.9 pA at +80 mV membrane step (Fig 19E, 19F). As expected from wild-type channel, no change
in unitary current is observed (Fig 19E, 19F). Wild-type TRPV2 had unitary conductance of 93.4 ± 12.0 pS
(n = 7), while R619P mutant have 97.4 ± 8.2 pS (n = 4). Student t-test shows there are no differences
between unitary conductance of wild-type and R619P mutant channel. (p = 0.84). This result clearly shows
abolishing charged residue at 619 position does not convert TRPV2 to TRPV3 like. However, the question
remains whether if removal of both E614 and R619 residues convert TRPV2 to TRPV3 like.
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Figure 2014: 2-APB induced Q651E-P656R mutant TRPV3 activities in excised membrane patches.
HEK-293 cell is transfected with the EGFP-Q651E-P656R-hTRPV3 mutant channel and subjected to excised
inside-out patch clamp electrophysiology. Membrane potential is clamped to -80 mV (A) and +80 mV (B), and
5 different time intervals in a representative patch is shown. Leak-subtracted zero current amplitudes are
presented with closed channel state (c) indicated by dashed lines. A. No channel openings are observed when
the membrane potential is stepped to -80 mV under control condition. B. Occasional channel opening is found
when the membrane potential is stepped to +80mV under control condition. C, D. Addition of 40µM 2-APB to
the cytosolic face of the patch elicits channel activity at both -80 mV (C) and +80 mV (D). Consistently with
wild-type channel, more channel activity is found in +80mV membrane step. The red box shows an enlarged
view of single channel activity across 200 ms. E, F. All-points histograms of the data shown in panels A-D in
the absence (control, black circles) and presence (green circles) of 40 μM 2-APB measured at -80 mV (E) or
+80 mV (F) are shown. Insets show expanded views of the data in panels E and F. Lines represent fits of the
data to Gaussians; the position of the first major peak is 14.6 pA at -80 mV (E, magenta line) and 11.2 pA at
+80 mV (F, magenta line). G. The unitary conductance is calculated from the unitary current by formula G=I/V.
Compared to the wild-type rat TRPV2 channel, Q651E-P656R-TRPV3 mutant did not change unitary
conductance. Wild-type TRPV3 channel has a unitary conductance of 173.3 ± 16.5 pS (n = 4), while Q651EP656R mutant has a unitary conductance of 154.6 ± 4.5 pS (n = 3). No statistical difference is observed (p =
0.34).

55

To address this question equivalent residues of hTRPV3 Q646 and P651 residues are mutated to glutamic
acid and arginine, making hTRPV3 channels to TRPV2 like. EGFP-Q651E-P656R-hTRPV3 mutant
channel is created by PCR mutagenesis and cloning. Then HEK-293 cells expressing EGFP-Q651E-P656RhTRPV3 protein is subjected to excised inside-out patch clamp electrophysiology. Similar to the wild-type
hTRPV3 sporadic channel openings are observed under control condition when the membrane is stepped
to +80mV (Fig 20B), but no channel activities are observed when stepped to -80mV (Fig 20A). As expected
superfusion of 40 μM 2-APB to cytosolic face elicit robust channel activity (Fig 20C, 20D). Note the single
channel activities have a clearly definable open state similar to wild-type TRPV3 (Fig 20D). Gaussians fit
of all point histogram reveals unitary current of 14.6 pA at -80 mV (Fig 20E, magenta line) and 11.2 pA at
+80 mV (Fig 20F, magenta line). Q651E-P656R-hTRPV3 mutant channels have a unitary conductance of
154.6 ± 4.5 pS (n = 3) while wild-type TRPV3 channels have a unitary conductance of 173.3 ± 16.5 pS
(Fig 20G, n = 4). There is no statistical difference between two groups (p = 0.34). Results clearly show the
addition of charged amino acid at Q651 and P656 site does not reduce the size of the unitary conductance
of TRPV3. The Q651E-P656R mutation did not significantly reduce TRPV3 channel unitary conductance,
nor make TRPV3 single channel current flickering. Together with R619P-rTRPV2 mutant single channel
activity we conclude, there is E651 and K656 residue does not regulate unitary conductance in TRPV
channels. However, does E651 and K656 mutation cause further change in biophysical properties remains
to be explored.
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Figure21: CBD induced TRPV2 current is enhanced by H2O2.
A representative HEK-293 cell expressing EGFP-rTRPV2 is voltage clamped in the whole-cell mode to measure
rTRPV2 current response to voltage ramp. A. Application of 300 µM CBD induces TRPV2 current slowly
increase Istep (black circle) and Itail measured (white circle). TRPV2 current is further increased by the addition
of 1mM H2O2. Currents in panels B and C were measured at the times indicated by letters: a., control; b., 2-APB;
c., 2-APB + RuR B. The representative current response to voltage ramp is shown under control (black line),
300 µM CBD (green line) and 300 µM CBD plus 1 mM H2O2 (blue line). H2O2 enhances both outward current
and Itail of rTRPV2 channels but did not increase in the inward current of TRPV2 channel. C. I-V relations
measured in the absence and presence of CBD and H2O2 (data from panel B) are shown. I-V relation shows an
increase of outward current in TRPV2 following the addition of H2O2. Currents in panels B and C were measured
at the times in panel A indicated by letters: a., control; b., 2-APB; c., 2-APB + RuR. D. On average tail current
of TRPV2 measures 0.8 ± 0.4 nA if CBD is applied and further increased to 1.9 ± 0.5 nA if CBD and H2O2 are
applied together. Application of H2O2 and CBD (n=4) increase the normalized Itail by 13.7 ± 2.6 times to that of
control current while CBD alone (n=4) increased normalized Itail to 5.6 ± 1.8 times of control. A significant
difference is found between two groups (p<0.05; df = 6). * indicate the mean of normalized Itail between CBD
group and CBD + H2O2 group is significantly different measured by student t-test with α<0.05 for a significant
difference between groups.
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7. Hydrogen peroxide enhances cannabidiol induced TRPVs current
TRPV2 channel is known to mediate pro-inflammatory activation of macrophages and leukocytes64,66,68.
However, how do pro-inflammatory stimuli, such as LPS, alters TRPV2 channel gating is largely unknown.
Activated microglia is known to produce ROS for signaling and bacterial killing. Furthermore, other TRP
channels such as TRPV1 current is known to be enhanced by ROS such as H2O2111,112. Given their similarity,
we hypothesized TRPV2 current may also enhance by H2O2.
To study the H2O2 effect on TRPV2, EGFP-tagged TRPV2 transfected HEK-293 cells are subjected to
whole cell voltage clamp while a voltage ramp protocol from -80 mV to +80 mV (1 s duration) is repeatedly
applied. As expected no TRPV2 current are detected under control condition (Fig 21A, 21B black line),
and the addition of 300 μM cannabidiol to be bath (extracellular face) induces both +80mV step current
and -80mV tail current (Fig 21A, 21B green line). Co-application of 1mM H2O2 and 300 μM CBD further
increase both 80mV step current and -80mV tail current (Fig 21A, 21B blue line). I-V curve shows no
current under control condition (Fig 21C black line), and 300μM CBD induces outward rectified current as
expected (Fig 21C green line). The addition of 1 mM H2O2 increases the outward current but did not enhance
the inward current (Fig 21C blue line). On average, 300 μM CBD induces a tail current of 0.84 ± 0.37 nA
while co-application of 1mM H2O2 and 300 μM cannabidiol induces tail current equals to 1.9 ± 0.5 nA (Fig
21D). Our result shows H2O2 significantly increases CBD induced TRPV2 current (p=0.04; Fig 21D). As
expected from published TRPV1 study H2O2 enhances TRPV2 channel sensitivity to agonist111,112.
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Figure 22: CBD and H2O2 induced TRPV2 activities in excised membrane patches.
HEK-293 cell is transfected with EGFP-rTRPV2 and subjected to excised inside-out patch clamp
electrophysiology. Dash lines indicate leak-subtracted zero current amplitudes, which correspond to the closed
channel state (c). A, B. No channel opening is observed under control condition whether the membrane is stepped
to -80 mV (A), or to +80 mV (B). C, D. Application of 300 µM CBD to cytosolic face elicit TRPV2 opening in
-80 mV (C), and +80 mV (D). Note the channel activity is larger in +80 mV step compared to -80 mV step. E,
F. Addition of 1 mM H2O2 further increased channel opening compared to CBD alone in both -80 mV (E) and
+80mV (F) steps. The highly erratic activity of TRPV2 channel is observed. The red box shows an enlarged
view of single channel activity across 200 ms. G. All point histogram shows a current response to -80 mV
membrane step measured across 20 seconds (data in A, C, E). H. Enlarged view of panel G. Only 0 current peak
is found in control condition (black circle). The addition of CBD induces open channel peaks (green circle) and
co-application of CBD and H2O2 further increased the size of open channel peaks (blue circle). The addition of
H2O2 did not cause a shift of open channel peak compared to CBD alone. CBD induced unitary current first
major peak equals to 8.1 pA and second major peak of equals to 13.7 pA. Co-application of CBD and H2O2
induces first major peak equals to 8.0 pA and second major peak equals 14.7 pA. I. All point histogram of the
current response to +80mV membrane step measured across 20 seconds (data in A control black circle, D CBD
green circle, and F CBD + H2O2 blue circle). J. Enlarged view of panel I. CBD induced TRPV2 current (green
circle) has single TRPV2 channel opening with first major peak equals 5.9 pA and second major peak equals
13.4 pA. The addition of H2O2 to CBD induces highly erratic TRPV2 channel activity with possibly high channel
noise and the existence of sub-conductance state at +80mV that precludes unambiguous determination of the
single current amplitude (blue circle).
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Whole cell current can be denoted by formula as I=NiPo (equation 6). To better understand whether H2O2
alters NPo or i, excised inside-out patch clamp electrophysiology were used to observe the effect of H2O2
on CBD induced current in EGFP-tagged TRPV2 expressing HEK-293 cells. Under control condition, no
current was observed in representative records whether membrane potential was stepped to -80 mV (Fig
22A) or to +80 mV (Fig 22B). Application of 300 μM CBD induced TRPV2 channel activation at both 80mV membrane step (Fig 22C) and +80 mV membrane step (Fig 22D). Again higher single channel
actives are observed in +80 mV membrane step compared to -80mV membrane step. Co-application of 1
mM H2O2 and 300 μM CBD further increased TRPV2 channel activates in both -80 mV and +80 mV step
(Fig 22E, 22F). When membrane potential was stepped to +80 mV, co-application of H2O2 and CBD
increased TRPV2 channel activity too high to discern closed channel state (Fig 22F). All point histogram
shows that co-application of CBD and H2O2 did not change the unitary current of TRPV2 in -80 mV step
(Fig 22G, 22H). As expected, no open channel peaks were observed under control condition in -80 mV
membrane step (Fig 22G black circle) or +80 mV membrane step (Fig 22I, black circle). The addition of
300 μM CBD induced two major open channel peaks in -80 mV membrane step (Fig 15G, 15H green circle)
and in +80mV membrane step (Fig 22G, 22H green circle). In -80 mV membrane step, the first major peak
has a unitary current of 8.1pA (Fig 22H magenta line), and the second major peak has a unitary current of
13.7pA (Fig 22H cyan line). Co-application of CBD and H2O2 robustly increased the size of open channel
peaks but did not change the unitary current of the open channel peaks (Fig 22H). Gaussian fit shows first
major open channel peak have a unitary current of 8.0 pA (Fig 22H orange line), and second major open
channel peak have a unitary current of 14.7 pA (Fig 22G, 22H). In +80mV membrane step, 300μM CBD
induced two major open channel peaks in all point histogram (Fig 22I, 22J). First major peak has a unitary
current of 5.9 pA (Fig 22J magenta line) and the second peak has the unitary current of 13.4pA (Fig 22J
cyan line). At +80 mV membrane step, it was not able to measure the unitary current of CBD and H2O2 coapplication as all point histogram was too flat and widespread for successful Gaussian fit (Fig 22I, 22J).
This result highlight ability of H2O2 enhancing TRPV2 Po
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Figure 153: H2O2 effect on CBD induced TRPV2 unitary current.
NPo is measured by Clampfit single channel search program (see Method 7f) and unitary current are
measured by Gaussian fit from the open channel peak of all point histogram. A. NPo of CBD induced
TRPV2 activation is enhanced significantly by H2O2 (p = 0.05). NPo under CBD condition equals to 0.12
± 0.04, and CBD + H2O2 equals 0.84 ± 0.38. B. Unlike NPo, unitary current did not change significantly
with or without addition of H2O2 (p = 0.15). CBD induced unitary current equals to 8.4 ± 0.1pA and CBD
plus H2O induced unitary current of 8.7 ± 0.2. This result shows H2O2 enhances TRPV2 by increases its
NPo. Statics is analyzed by student t-test with α<0.05 for significance.

too high, converting the measurement of the single channel current to macroscopic current. Co-application
of CBD and H2O2 significantly increased NPo of TRPV2 (NPo = 0.84 ± 0.38) compared to CBD alone (0.12
± 0.04, p = 0.05, Fig 23A). However, no statistically significant difference were found between unitary
conductance of CBD induced TRPV2 current (8.4 ± 0.1 pA) and CBD plus H2O2 induced TRPV2 current
(8.7 ± 0.2 pA, p = 0.15, Fig 23B). This result confirms that H2O2 enhances NPo but not the unitary current
of TRPV2.
The question remains whether if H2O2 enhances CBD effect on TRPV2, or CBD and H2O2 function
separately to activate the TRPV2 channel. To examine whether H2O2 alone have the ability to activate
TRPV2 channel, excised inside-out voltage clamp electrophysiology were used to measure the current
response of EGFP-tagged-rTRPV2 channel to the H2O2 application. As expected no channel opening were
found under control condition (Fig 24A, 24B). Application of 1 mM H2O2 (Fig 24C, 24D), or 10 mM H2O2
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Figure 24: H2O2 alone does not activate TRPV2.
Currents recorded in a representative inside-out patch excised from a HEK-293 cell expressing EGFPrTRPV2 are measured in the absence and presence of H2O2 (1 mM or 10 mM) at -80mV or +80mV.
Dash lines indicate the leak-subtracted zero current amplitude, which corresponds to the closed-channel
state (c). 5 representative time intervals are shown for each of following experimental conditions; control
condition (no H2O2) at -80mV (A) or +80mV (B); 1 mM H2O2 at -80 mV (C) or +80 mV (D); 10mM
H2O2 at -80 mV (E) or +80mV (F). Note that no channel openings are detected. G. All-points histograms
of data shown in panels A, C, E (control, black circles; 1 mM H2O2, green circles; 10 mM H2O2, blue
circles). H. All-points histograms of data shown in panels B, D, F (control, black circles; 1 mM H2O2,
green circles; 10 mM H2O2, blue circles). Data in G and H represent 18 seconds of total recording time
are shown. I. NPO values are calculated from discrete event analysis of 18 s recordings under the
conditions shown in A-F (Single Channel Search, Clampfit 10).

(Fig 24E, 24F) did not elicit channel activity in representative traces regardless -80 mV or +80 mV
membrane steps. All point histogram confirms that no open channel peak is observed in 0 mM, 1 mM or
10 mM H2O2 application (Fig 24G, 24H). No channel opening was detected by single channel search
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Figure 25: Locations of candidate Cys residues at the inter-subunit interface between ARDs
in TRPV2.
A. Structure of one subunit in TRPV2 tetrameric channel is shown in ribbon representation. Four
cysteine residues tested in this study are shown in space filling representation. Domains and motifs
are individually colored for clarity: ARD, magenta; HLH linker, blue; S1-S6 TM domain, cyan; TRP
helix, purple; CTD, green. The point of contact between ARDs in adjacent subunits is indicated by
the black box, which is magnified in panel B. B. Selected Cys residues are shown in space filling
representation (cyan, carbon; yellow, sulphur). C206 and C219 residues in one TRPV2 subunit
(orange ribbons) are located close to C343 and C704 in the neighboring subunit (colored as in panel
A). The proximity of these residues to one another suggests that inter-subunit disulfides bonds could
form, and might constrain the relative positions of ARDs that favors an open-channel conformation.
Representations shown here are based on the TRPV2 cryo-EM structure (pdb: 5hi9) determined by
Huynh, et al. (2016)1. Graphical representations were created using VMD 1.9.3.

program of Clampfit software (Fig 24I). The result indicates H2O2 only have the ability to enhance CBD
induced TRPV2 current but may not activate TRPV2 channel by itself.
To summarize, H2O2 enhances CBD induced TRPV2 channel activation, but may not activate TRPV2
channel by itself. Unlike DCPIB, H2O2 did not affect unitary conductance of TRPV2 but only affected NPo
of TRPV2. H2O2 is commonly produced during immune cell activation75. This result indicates TRPV2 may
be primed to activate in the environment with high inflammation and high ROS activity.
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8. Cysteine residues in ARD domain is crucial for hydrogen peroxide sensitivity
The rotation of ARD in TRPV channels are thought to trigger TRPV channel activation. For example, the
rotation of ARD during heating the environment is thought to drag transmembrane domains to induce
conformational change leading to the opening of TRPV channel gate29. ARD domain in TRPV channels
contains multiple cysteine residues which can serve as a site for H2O2 modulations. The cysteine residues
in ARD are shown to form disulfide bonds with neighboring CTD in TRPV138. The formation of disulfide
connection can stabilize open channel state or closed channel state, and therefore promote opening or
closing of TRPV channel38. TRPV2 channel contains four cysteine residues that locate closely to cysteine
residues of neighboring subunits (Fig 25A). Cysteine 206 (C206) and cysteine 219 (C219) on ARD of one
TRPV2 subunit are located near cysteine 334 (C334) on ARD and cysteine (C704) on CTD neighboring
TRPV2 subunits (Fig 25B). Of those residues, C206 and C334 are unique to TRPV2 and not conserved in
TRPV1 or TRPV3. The formation of inter-subunit or intra-subunit disulfide connections between ARD
domains may lock the ARD domain to promote the open state. We hypothesize that mutation of those
cysteine residues abolished H2O2 sensitivity in TRPV2 channels.
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Figure 166: CBD induced current in TRPV2 C206A is not potentiated by H2O2.
Point mutation of C206A are introduced to TRPV2 channels using PCR. Then a representative HEK293 cell
expressing GFP-C206A-rTRPV2 is voltage clamped in the whole-cell mode. A. Istep at +80mV and Itail at 80mV are measured across time. Addition of 300 µM CBD to bath (extracellular face) elicits both Istep at +80mV
and Itail at -80mV, but co-application of 1mM H2O2 together with 300 µM CBD (CBD + H2O2) did not enhance
current amplitude. B. Ramp I-V relations measured under control (a, black line), CBD (b, green line) and CBD
+ H2O2 (c. blue line) are shown. I-V curve of CBD induced current overlaps with the I-V curve in CBD + H2O2,
indicating H2O2 did not enhance the CBD induced TRPV2 current at any voltage. Currents were measured at
the times in panel A (a., control; b., CBD; c., CBD + H2O2). C. Mean normalized currents in the presence of
CBD (black bar; 13.30 ± 3.19-fold increase compared to control) or CBD + H2O2 (open bar; 11.42 ± 2.32 fold
increase compared to control)) are not different (P =0.48, df = 6, n = 4 each).

Mutation of four subunits was introduced into EGFP-tagged rTRPV2 by site-directed mutagenesis and then
cloned mutant channel protein are transfected into HEK-293 cells (see Method 1 and 2). Then mutant
channel expression HEK-293 cells were subjected to whole cell voltage clamp, and a voltage ramp protocol
from -80 mV to +80 mV (1 s duration) is repeatedly delivered to the cell in the absence and presence of
300 μM CBD. C206 to alanine (C206A) mutation abolished the H2O2 sensitivity in TRPV2. No current are
detected under control condition, while the addition of CBD to cytosolic face increased both +80mV steady
state step (Istep) and -80mV instantaneous tail current (Itail) in the C206A-TRPV2 mutant (Fig 26A).
However, co-application of H2O2 with CBD did not enhance those currents (Fig 19A). CBD and H2O2 coapplication induced current (Fig 26B black line) showed same I-V relation compared to CBD induced
C206A-TRPV2 current (Fig 26B green line). To measure H2O2 induced current increase, -80mV Itail are
normalized to control. CBD alone increased -80mV Itail by 11.42 ± 2.32 fold compared to control, while
CBD plus H2O2 increased Itail by 13.30 ± 3.19 fold compared to control (Fig 26C). No significant change is
detected (p=0.48; Fig 19C), indicating removal of C206 abolished H2O2 effect on TRPV2.
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Figure 27: CBD induced C219A mutant TRPV2 current is enhanced by H2O2.
Point mutation of C219A is introduced to TRPV2 channels using PCR. The representative HEK-293 cell
expressing EGFP-C219A-rTRPV2 is voltage clamped in the whole-cell mode. A. Istep at +80 mV and Itail at -80
mV are measured over time under control (a), 300 µM CBD (b) and CBD plus H2O2 (c). The addition of CBD
to extracellular side elicits both Istep and Itail. The addition of 1mM H2O2 to 300µM CBD elicit larger Istep at +80
mV and Itail at -80 mV. B. IV relation of representative traces of control (a, black line), CBD (b, green line) and
CBD plus H2O2 (c. blue line) are shown. 300 µM CBD plus 1 mM H2O2 induces an increase in both inward and
outward current compared to CBD alone. Currents in panels were measured at the times in panel A indicated by
letters: a., control; b., CBD; c., CBD + H2O2. C. CBD increased current 3.8 ± 0.5 fold compared to control and
CBD plus H2O2 increased TRPV2 current 12.4 ± 4.3 fold compared to control (P =0.12, df = 4, n = 3 each). No
statistical difference are found between CBD and CBD plus H2O2 condition.

On the other hand, mutation of C219 residue to alanine (C219A) did not alter H2O2 sensitivity in TRPV2.
As expected, no current are detected under control condition while application CBD increased both +80mV
Istep and -80 mV Itail in C219A mutant TRPV2 (Fig 27A). However, application of H2O2 still enhanced both
+80 mV

Istep

and -80mV Itail in C219A-rTRPV2 (Fig 27A). I-V relation of H2O2 plus CBD elicits larger

inward current and outward current (Fig 27B blue line) compared to that of CBD induced current (Fig 27B
green line). Normalized current shows that CBD application causes 3.8 ± 0.5 fold increase in Itail compared
to control while CBD plus H2O2 increased Itail 12.4 ± 4.3 fold compared to control (Fig 27C). However, coapplication of CBD plus H2O2 did not induce statistically significant current increase compared to CBD
alone (P =0.12, n = 3 each; Fig 27C). Lack of statistical significance is thought to cause by high variability
between groups. Increasing sample number may aid to elucidate effect on C219A mutant.
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Figure 28: CBD induced C334A mutant TRPV2 current is enhanced by H2O2.
Point mutation of C334A is introduced to TRPV2 channels using PCR. The representative HEK-293 cell
expressing EGFP-C334A-rTRPV2 is voltage clamped in the whole-cell mode. A. Istep at +80mV and Itail at 80mV are measured over time under control (a), 300 µM CBD (b) and CBD plus H2O2 (c). The addition of CBD
to extracellular face elicits both Istep and Itail within 20 seconds. The addition of 1 mM H2O2 to 300 µM CBD
elicit larger Istep at +80 mV and Itail at -80 mV. B. IV relation of representative traces of control (a, black line),
CBD (b, green line) and CBD plus H2O2 (c. blue line) are shown. 300 µM CBD plus 1 mM H2O2 induces an
increase in both inward and outward current. Currents in panels were measured at the times in panel A indicated
by letters: a., control; b., CBD; c., CBD + H2O2. C. H2O2 increased CBD increased current 7.96 ± 2.27 fold
compared to control and CBD plus H2O2 increased TRPV2 current 11.3 ± 2.9 fold compared to control. The
result shows significant difference between CBD condition current and CBD plus H2O2 condition (P =0.02, df
= 5, n = 6 each).

Mutation of C334 to alanine (C334A) also did not abolish H2O2 effect on TRPV2. As expected, no current
were detected under control condition while application CBD increased both +80mV Istep and -80mV Itail in
C219A mutant TRPV2 (Fig 28A). Both +80mV Istep and -80mV Itail were further enhanced by co-application
of H2O2 and CBD (Fig 28A). CBD induced rectified I-V curve (Fig 28B, green line), and co-application of
H2O2 and CBD enhanced both inward and outward current (Fig 28B, blue line). Co-application of CBD and
H2O2 induced a significantly larger normalized current (11.9 ± 2.9 fold increase compared to control)
compared to CBD alone (8.0 ± 2.3 fold compared to control, p=0.02; Fig 28C). This result shows mutation
of C334A has no effect on TRPV2 H2O2 sensitivity.
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Figure 29: CBD induced C704A mutant TRPV2 current is not enhanced by H2O2.
Point mutation of C704A is introduced to TRPV2 channels using PCR. The representative HEK-293 cell
expressing EGFP-C704A-rTRPV2 is voltage clamped in the whole-cell mode. A. Istep at +80mV and Itail at 80mV are measured over time under control (a), 300µM CBD (b) and CBD plus H2O2 (c). The addition of CBD
to extracellular face elicits both Istep and Itail. Note the slow rise of the current. The addition of 1mM H2O2 to
300µM CBD did not elicit additional current. B. IV relation of representative traces of control (a, black line),
CBD (b, green line) and CBD plus H2O2 (c. blue line) are shown. Application of 300µM CBD induced an increase
in both inward and outward current, while co-application of 1mM H2O2 and 300μM CBD did not change the
current response. Currents in panels were measured at the times in panel A indicated by letters: a., control; b.,
CBD; c., CBD + H2O2. C. CBD increased current 7.6 ± 1.0 compared to control and CBD plus H2O2 increased
TRPV2 current 8.8 ± 2.4 times compared to control. The difference between two groups are significant (P =0.55,
n = 3 each). Statistics are analyzed by paired t-test with result considered significantly different if α<0.05.

Finally, mutation of C704 residue to alanine (C704A) abolished H2O2 sensitivity in TRPV2. No current
were detected under control condition (Fig 29A). The addition of 300 μM CBD increased both +80 mV Istep
and -80mV Itail in the C704A-rTRPV2 mutant, but co-application of 1mM H2O2 and 300 μM CBD did not
further increase those currents (Fig 29A). I-V curve also shows co-application of CBD and H2O2 (Fig 29B,
blue line) have same I-V relationship compared to CBD alone (Fig 29B, green line). CBD alone increased
-80mV normalized Itail by 11.4 ± 2.3 fold compared to control while CBD plus H2O2 increased normalized
Itail by 13.3 ± 3.2 fold (Fig 29C). No significant change in normalized Itail was detected (p=0.55; Fig 29C),
indicating that C704A mutation abolishes TRPV2 sensitivity to H2O2. This result suggests C704 residue is
a site for H2O2 modulation.
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Figure 30: H2O2 enhance CBD induced TRPV2 activity in excised membrane patches.
HEK-293 cell is transfected with EGFP- rTRPV2 channel and subjected to excised inside-out patch clamp
electrophysiology. The current response to -80 mV membrane potential step is measured. Representative current
response across 5 time intervals under control condition (A), 300 μM CBD (B), and co-application of 300 μM
CBD and 1 mM H2O2 (C) are shown. Dash lines indicate leak-subtracted zero current amplitudes corresponding
to the closed channel state (c). A. Under control condition, no channel activity are observed. B. Application of
300 μM CBD induces the erratic activity of TRPV2 C. Addition of 1 mM H2O2 on top of 300 μM CBD enhanced
TRPV2 activity. The red box shows an enlarged view of single channel activity across 200 ms. D. The current
response to -80 mV is normalized to control and averaged across 10 sweeps to construct average current response
(see Method). The addition of CBD induces current activity (green line) higher than control condition (black
line). CBD and H2O2 co-application induced current (blue line) that is larger than CBD induced current (green
line). E. Mean current response in D is further averaged to calculate ensemble average current response across
20 seconds of measurement. Co-application of CBD and H2O2 further increases channel opening compared to
CBD alone.

Those result revealed that cysteine residue at 206 and 704 site is important in H2O2 modulation of TRPV2
channel opening. Mutation of either C206A or C704A was sufficient to abolish H2O2 sensitivity in TRPV2
channel. In order to confirm C704A mutant abolishes H2O2 sensitivity in rTRPV2, excised inside-out patch
clamp electrophysiology was utilized. Since CBD and H2O2 induced high NPo when membrane step to
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+80mV, the effect of CBD and H2O2 co-application during -80mV membrane step were used to quantify
TRPV2 channel open probability. For control, EGFP-tagged rTRPV2 transfected HEK-293 were subjected
to excised inside-out patch. As expected, -80 mV membrane step alone did not cause TRPV2 channel
activation in representative traces (Fig 30A). Application of 300 μM CBD elicits rTRPV2 channel opening
(Fig 30B). Further addition of 1 mM H2O2 induced higher channel activity as expected (Fig 30C). The
current response across 18 seconds was collected (Fig 30D) and subjected to ensemble average
quantification (Fig 23E). The average current across 10 sweeps are shown in Fig 26D. Co-application of
CBD and H2O2 induced higher average current trance (Fig 30D, blue line) compared to CBD alone (Fig
30D, green line). Ensemble average shows CBD alone induced 0.6 pA, while co-application of CBD and
H2O2 induced 4.3 pA current in average across 18 seconds (Fig 30D).
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Figure 31: H2O2 does not enhance CBD induced C704-rTRPV2 activity in excised membrane patches.
HEK-293 cell is transfected with the C704R-mutatnt rTRPV2 channel and subjected to excised inside-out patch
clamp electrophysiology. The current response to -80 mV membrane potential step is measured. Representative
current response across 5 time intervals under control condition (A), 300 μM CBD (B), and co-application of
300 μM CBD and 1mM H2O2 (C) are shown. Dash lines indicate leak-subtracted zero current amplitudes
corresponding to the closed channel state (c). A. Under control condition, no channel activity are observed. B.
Application of 300 μM CBD induces the erratic activity of TRPV2 C. However, unlike wild-type TRPV2
channel addition of 1mM H2O2 on top of 300μM CBD did not enhance TRPV2 activity. The red box shows an
enlarged view of single channel activity across 200 ms. D. The current responses to in A-C are normalized to
control condition (A) and averaged across 10 sweeps to construct average current response (see Method). The
addition of CBD induces current activity (green line) higher than control condition (black line). CBD and H2O2
co-application induced current (blue line) that is larger than control current but equal to CBD induced current
(green line). E. Mean current response in D is further averaged to calculate ensemble average current response
across 20 seconds of measurement. Co-application of CBD and H2O2 did not increase channel opening compared
to CBD alone.

Next EGFP-tagged C704A-rTRPV2 are subjected to excised inside-out patch clamp electrophysiology to
examine the effect of H2O2 sensitivity on C704A-rTRPV2. In the C704A-rTRPV2 mutant, H2O2 did not
enhance single channel activity of CBD induced TRPV2 current consistent with the whole cell current
71

Figure 3217: Ensemble average analysis of H2O2 enhancement of CBD induced TRPV2
current.
Ensemble average result of CBD plus H2O2 is divided by CBD alone to calculate fold increase
of H2O2 induced TRPV2 channel current potentiation. In wild-type TRPV2 channel 1 mM
H2O2 are able to increase the 300 μM CBD induced TRPV2 current by 6.1 ± 1.4 folds.
Application of 1 mM H2O2 to C704A mutant TRPV2 channel only increased 300μM CBD
induced current by 1.6 ± 0.4 fold. C704A mutation significantly reduced H2O2 potentiation (p
= 0.03, n = 3 each group).

record. Similar to wild-type TRPV2 channel, stepping membrane potential to -80mV alone did not activate
C704A mutant TRPV2 channel (Fig 31A). Application of 300 μM CBD induced multiple TRPV2 opening
(Fig 31B). However, unlike wild-type channel, the addition of 1 mM H2O2 did not enhance CBD induced
C704A mutant TRPV2 channel activity (Fig 31C). Abolished TRPV2 channel H2O2 sensitivity is evident
as averaged current traces of CBD plus H2O2 (Fig 31D, blue line) overlaps with averaged current trance of
CBD alone (Fig 31D, green line). Ensemble average shows CBD alone induces 0.2 pA, while co-application
of CBD and H2O2 induces 0.2 pA current on average (Fig 31D). In wild-type, TRPV2 channel addition of
H2O2 increased CBD induced TRPV2 current by 6.1 ± 1.4 fold (n=3), while the addition of H2O2 to C704A
mutant increased CBD induced TRPV2 current by 1.6 ± 0.4 fold (n=3; Fig 32). The effect of H2O2
enhancement of CBD induced TRPV2 current is significantly different in wild-type and C704A mutant
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Figure 33: Cysteine 678 residue provide a potential site for H2O2 modulation.
A. Structure of one subunit in TRPV2 channel is shown in ribbon representation. The cysteine residue tested
in this study are shown in space filling representation. Domains and motifs are individually colored for
clarity: ARD, magenta; HLH linker, blue; S1-S6 TM domain, cyan; TRP helix, purple; CTD, green. The the
hook structure is indicated by the black box, which is magnified in panel B. TRPV2 structure exhibits a
unique ‘hook’ structure between the TRP helix and downstream CTD. The tip of the hook points toward the
lipid bilayer. B. An enlarged view of the hook structure (dashed box in panel A) highlights the position of
C678 (space filling representation: cyan, carbon; yellow, sulphur). Representations shown here are based on
the TRPV2 cryo-EM structure (pdb: 5hi9) determined by Huynh, et al. (2016)1. Graphical representations
were created using VMD 1.9.3.

(p=0.03; Fig 32). This confirms that H2O2 enhances CBD induced TRPV2 current, and C704A mutation
abolished H2O2 sensitivity.
Additionally to ARD and CTD, TRPV2 also contains a hook structure connecting TRP domain to CTD
(Fig 33A, 33B). This structure is unique to TRPV2 and not found in TRPV1. At the tip of hook structure,
a cysteine at 678 position is found. Given this hook structure point toward extracellular matrix and come
close proximity to the inner leaflet of plasma membrane, it is possible that this portion of TRPV2 channel
may come to contact with lipid molecules. The importance of C678 is not known. To examine the C678
effect on H2O2 sensitivity, the C678 residue is mutated to arginine (C678R) and TRPV2 channel sensitivity
to H2O2 was examined.
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Figure 184: H2O2 enhances CBD induced C678R mutant TRPV2 activity in excised membrane patches.
C619R mutation is introduced by PCR and transfected into the HEK-293 cell. C619R-mutant rTRPV2
transfected HEK-293 are subjected to excised inside-out patch clamp electrophysiology. Dash lines indicate
leak-subtracted zero current amplitudes, which correspond to the closed channel state (c). A, B. No channel
opening is observed under control condition whether the membrane is stepped to -80 mV (A), or to +80 mV (B).
C, D. Application of 300 µM CBD to cytosolic face elicit TRPV2 channel opening in -80 mV (C), and +80 mV
(D). E, F. Addition of 1 mM H2O2 further increases channel opening compared to CBD alone in both -80 mV
(E) and +80 mV (F) steps. The red box shows an enlarged view of single channel activity across 200 ms. G. All
point histogram summarize the current response to -80 mV membrane step in control (A), 300 µM CBD (C) and
300 µM CBD plus 1 mM H2O2 (E). Insets show an enlarged view of panel G. Only 0 current peak is found in
control condition (black circle). The addition of CBD induces open channel peaks (green circle) and coapplication of CBD and H2O2 further increased the size of open channel peaks (blue circle) but did not cause a
shift of open channel peak. CBD induced unitary current first peak equals to 6.3 pA. Co-application of CBD and
H2O2 induces first peak measures 6.5 pA. H. All point histogram summarize the current response to +80 mV
membrane step in control (B), 300 µM CBD (D) and 300 µM CBD plus 1 mM H2O2 (F). Insets show an enlarged
view of panel H. Open channel peak is found after addition of CBD (green circle), and co-application of CBD
and H2O2 further increased the size of open channel peaks (blue circle). The addition of H2O2 did not cause a
shift of open channel peak. CBD induced current have the first peak equals to 4.2 pA, and co-application of CBD
and H2O2 induced current has the first peak equals to 4.2 pA. I. Paired student t-test across three cells shows
there is no statistically significant difference between CBD condition and CBD plus H2O2 condition. CBD
induced NPo equals to 0.11 ± 0.06 and CBD plus H2O2 induced NPo equals to 0.22 ± 0.11. No statistical
significant difference is found (p = 0.32, n = 3 each). Statistics are considered significant if α<0.05.
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EGFP-C678R-rTRPV2 expression HEK-293 cells were subjected to excised inside-out patch clamp
electrophysiology. Similar to wild-type rTRPV2, no channel activity is observed in C678R-rTRPV2 under
control condition (Fig 34A, 34B). The addition of 300 μM CBD to cytosolic face induced single channel
activity in both -80mV membrane step and +80mV membrane step (Fig 34C, 34D). The result shows
C678R-rTRPV2 retains CBD sensitivity. Note that fast flickering activity was found, similar to wild-type
TRPV2. Co-application of 1 mM H2O2 and 300 μM CBD enhanced both -80mV and +80mV single channel
activity (Fig 34G, 34H). However, note that the effect of H2O2 enhancement was not as prominent as in
wild-type rTPRV2. Gaussian fits of all point histogram indicated that CBD induced unitary current have
first major open channel peak equals to 6.3pA, and co-application of CBD and H2O2 induced first major
open channel peak equals to 6.5 pA at -80mV membrane step (Fig 34G). At +80 mV membrane step, CBD
induced current have first major open channel peak equals to 4.2 pA, and co-application of CBD and H2O2
induced current to have first major open channel peak equals to 4.2 pA (Fig 34H). Note that C619R mutation
did not alter TRPV2 unitary conductance. The H2O2 application also did not change unitary conductance as
expected (Fig 34G, 34H). C619R mutation is able to abolish the H2O2 effect of enhancing TRPV2 current.
No statistically significant difference between CBD induced NPo (0.11 ± 0.06) and CBD plus H2O2
induced NPo (0.22 ± 0.11) were observed (p = 0.32). This result indicated that C678R mutation also reduces
H2O2 sensitivity, but may not as strongly as C704A mutation.
To summarize, C206, C678, and C704 are expected to be the site regulate H2O2 sensitivity in TRPV2, as
those residues are required for H2O2 enhancement of CBD induced TRPV2 current. However, C219 and
C334 residues are less likely involved in H2O2 sensitivity. At current knowledge, whether TRPV2 forms
intra-subunit disulfide bond between C206 and C704 residue is not known. Alternatively, C206 and C704
may form intra-subunit bonds with nearby cysteine residues. The intra-subunit disulfide bridge formation
is possible as suggested by TRPV1 study, further experiments are required to draw conclusions38. Hook is
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Chapter IV. Discussion
1. TRPV2 have fast flickering single channel activities with multiple conductance states
At the time of the study, TRPV2 single channel activity has not been fully demonstrated despite wide
distribution of TRPV2 across the body and proposed roles in osmosensation, mechanosensation, cardiac
cell function, innate immunity, and cancer cell migration20,66,70,113-115. In past three years, several studies
have tried to examine single channel activity of TRPV2 under different experimental conditions. Pottosin
et al and McGahon et al both used cell-attached patch clamp recording to examine native stretch-activated
single channel current in Jarket cells and rat retinal arteriole cells respectively70,104. Those currents are
believed to be TRPV2 related based on TRPV2 gene knockdown experiment70,104. The single channel
activities of purified rTRPV2 reconstituted in preformed asolectin liposomes is observed by Huynh et al
using excised inside-out patch clamp35. The reconstituted TRPV2 demonstrate functional PBC induced
rTRPV2 current in the artificial lipid bilayer, but effects of removing TRPV2 from the cellular environment
is unknown. Most recently, Zhang et al expressed resiniferatoxin (RTx) sensitive mutant TRPV2 (TRPV2QM) in HEK-293 cells and measured RTx activated TRPV2 current in excised inside-out patch clamp
configuration43. Despite efforts, results disagree with each other and interestingly no study have examined
wild-type TRPV2 activity in mammalian cells. The goal of this study is to characterize wild-type TRPV2
single channel activity in the widely used experimental system. Utilizing commonly used TRPV2 agonist
2-APB and CBD, here we report wild-type rTRPV2 single channel activity in HEK-293 cells under excised
inside-out patch clamp configuration.
Despite varieties of experimental conditions, all studies, including ours, reveal fast flickering activities of
TRPV235,43,70,104. Fast flickering activities are not due to experimental conditions as we demonstrate stable,
long time opening of TRPV1 and TRPV3 under same experimental conditions, consistent with the previous
publications48,105-107. Fast flickering activities are not agonist dependent as they are observed whether 2APB, CBD, PBC35, RTx43 or membrane stretch70,104 are used to activate TRPV2. Furthermore, fast
flickering activities are also independent of membrane voltage step and conducting ions; the fast flickering

76

activities are observed regardless whether membrane potential is stepped to negative or positive and
whether Na+ or K+ are used as conducting ion

35,43,70,104

. What accounts for the fast flickering nature of

TRPV2 is unknown, but results suggest TRPV2 rarely remain in open states for a prolonged time.
Also, TRPV2 have low Po without agonist. Consistently with previous results, there is no TRPV2 channel
opening detected without application of agonist18,43,70,104. Unlike TRPV1 and TRPV3 that have a low level
of NPo without the addition of agonist, TRPV2 is not activated by voltage step alone. Membrane steps up
to 120mV did not show single channel activity. This result is also shown in whole cell voltage clamp, no
current is observed without agonist addition, confirming TRPV2 is not activated without agonist 27,32,97.
Those results suggest polymodal gating of TRPV27,22. In addition to voltage agonists, temperature or
membrane stretch may be required for activation of TRPV2.
Other than fast flickering activity, TRPV2 also show subconductance. Subconductance current is found to
be approximately 10-20 pS. Interestingly subconductance is also observed in excised inside-out patch of
TRPV2-QM mutant channel expressed in HEK-293 cells43, but not prominent in purified TRPV2
reconstituted in liposome35. Those results suggest that subconductance may originate from channels
endogenously expressed by HEK-293. HEK-293 cells are known to endogenously express voltage gated
potassium116, voltage gated calcium (i.e. L-type CaV)66 and voltage gated sodium channels (i.e. NaV1.7)65
which may have unitary conductance approximately 10-20pS10,68. However, experimental conditions
exclude the possibility of K+, Ca+ and Na+ current. K+ and Ca2+ are chelated from solution hence
subconductance observed is not likely to originate from highly selective K+ and Ca2+ channels. Also, NaV1.7
is not likely since subconductance is no observed without application of 2-APB or CBD, indicating
subconductance channel cannot be activated by voltage step alone and subconductance is 2-APB and CBD
sensitive. Furthermore, TRPV2 current including subconductance is inhibited by addition of RuR to
intracellular face of the excised inside-out patch, indicating subconductance is generated by a calcium
conducting channel. HEK-293 also express numbers of chloride channels117. It is possible that
subconductance originate from ICl,swell. However, this hypothesis is rejected as the application of DCPIB, a
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potent Clswell blocker did not eliminate 2-APB induced subconductance current118,119. Furthermore, 2-APB
is suggested to inhibit ICl,swell current at concentrations above 100 μM109, making ICl,swell unlikely to present
in our experimental condition. Together those results suggest subconductance is a part of the TRPV2
biophysical property; indicating TRPV2 may have more than one open state with different unitary
conductance.
The flickering activity and subconductance states may represent dynamic pore. Given erratic and fast
flickering nature of TRPV2 current, TRPV2 may not have a “fixed” open state, rather they may flickering
between different open states. TRPV1 have shown to produce similar flickering single channel
activities120,121. Compared to Kv channels, cryo-EM of TRPV1 reveals dynamic pore structure which may
underlie flickering activity4, which suggest a similar mechanism in highly similar TRPV2 pore1,29.
Alternatively, two population of TRPV2 with two different unitary conductance may exist. For example,
TRPA1 unitary conductance is modulated by a high concentration of PI(4,5)P2122. Phosphoinositide
interacting regulator of TRP, a two transmembrane protein, is also shown to modulate unitary conductance
of TRPM8123. Mercado et al (2010) have shown PI(4,5)P2 also modulates TRPV2 current in excised insideout patch18. However, they were only able to observe macroscopic current, and it is not clear whether
PI(4,5)P2 affect NPo or unitary conductance of TRPV218. Those results suggest TRPV2 unitary
conductance may be modulated by the presence of auxiliary proteins and lipids.
Indeed our result shows that ICl,swell inhibitor DCPIB increased NPo and unitary conductance of TRPV2,
demonstrating TRPV2 unitary conductance can be modulated by pharmacological reagents. DCPIB is not
known to alter TRP activities previously. Our data reveals a noble effect of DCPIB enhancing 2-APB
induced TRPV2 and TRPV3 NPo in excised inside-out patch clamp electrophysiology. Interestingly,
DCPIB also increases unitary conductance of TRPV2 but did not affect unitary conductance of TRPV3.
The mechanism of DCPIB only alters TRPV2 unitary conductance is unknown. One hypothesis is that
DCPIB may shift TRPV2 activation to “fully opened” state. It is possible that 2-APB does not induce full
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opening of TRPV2 channel, and the addition of DCPIB promote the transition to the full opened state of
TRPV2.
In the end, reports from multiple labs indicate TRPV2 have fast flickering current with possible
subconductances, and we confirms same gating characteristic in wild-type TRPV2 activated by 2-APB and
CBD. Furthermore, we demonstrate TRPV2 NPo and unitary conductance can be modulated by
pharmacological reagents such as DCPIB, suggesting the potential of endogenous molecules modulating
TRPV2 unitary conductance and NPo. In addition to describing characteristics of TRPV2, we further
identified a pharmacological reagent that can act as TRPV2 co-agonist.

2. Rat TRPV2 have unitary conductance of approximately 100pS
Whole cell current (I) at any given time is the product of the number of functional channel in the membrane
(N), the unitary current of the channel (i) and open probability of the channel (Po; see equation 6). Hence
understanding unitary current and unitary conductance (i) is crucial for understanding biophysical property
of TRPV2. However, the unitary conductance of TRPV2 remains an enigma. Previous studies disagree on
what is TRPV2 unitary conductance. Studies by Pottosin et al and McGahon et al both showed small and
highly erratic stretch activated current in Jurkat cells and rat retinal arteriole cell respectively70,104. Pottosin
et al estimate that TRPV2 have a unitary conductance of approximately 40 pS while McGahon et al are not
able to measure unitary conductance due to small current size and fast flickering behavior of the
channel70,104. Also, note that unitary conductance in Pottosin study is not directly measured from single
channel record but rather estimated by dividing macroscopic current (I) measured by voltage ramp by
estimated number of open channels (NPo) measured in excised inside-out patch clamp recording70. On the
other spectrum, Huynh et al show reconstituted homotetrameric purified rTRPV2 in preformed asolectin
liposomes have a large conductance; excised inside-out patch clamp shows PBC induced unitary
conductance of approximately 304 pS35. Finally, Zhang et al report TRPV2-QM have RTx induced unitary
conductance of 101 pS at +90mV and 28 pS at -90mV in isometric 140 mM NaCl solution under excised
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inside-out patch clamp configuration43. The reasons for diverse TRPV2 unitary conductance is not known,
as each study in previously published works studies TRPV2 under a variety of experimental conditions and
may contain caveats. For example, Pottosin et al measured endogenous stretch activated current in Jurkat
cells, and their study suggests stretch activated current is TRPV2 because RNAi knockdown of TRPV2 or
application of rTRPV2 antibody and inhibitors abolishes stretch activated current70,104. These results
indicate TRPV2 is required for stretch activated current but does not indicate TRPV2 conducts stretched
activated current. Potentially TRPV2 can be a part of a group of channels that mediate stretch activated
current or TRPV2 may simply act as a modulator of an another stretch activated channel. Huynh et al
reconstituted homotetrameric purified rTRPV2 in preformed asolectin liposomes, which removes any
potential proteins and lipids interaction required for proper TRPV2 function but may provide nonmodulated TRPV2 biophysical property35. Finally, Zhang et al used RTx sensitive TRPV2-QM43. RTx is a
TRPV1 selective agonist that does not activate TRPV2 and TRPV343. In order to make TRPV2 sensitive to
RTx, Zhang et al mutated TRPV2 channel to more TRPV1 like. Interestingly only four residues are needed
to make TRPV2 sensitive to RTx43, but the overall effect of the mutations on TRPV2 gating is not clear,
and perhaps it is not surprising that TRPV2-QM have similar unitary conductance with TRPV1.
Here we report the unitary conductance of heterologously expressed wild-type rTRPV2 in HEK-293 cells
in excised inside-out patch clamp configuration. The unitary conductance is 103.8 pS at -80mV and 93.5
pS at +80mV membrane step when 2-APB is used as the agonist. When CBD is used as agonist unitary
conductance of rTRPV2 was 104.3 pS at -80mV and 105.4 pS at +80mV membrane step. Those result
suggest three characteristics of TRPV2 unitary conductance; TRPV2 unitary conductance remain
unchanged whether membrane voltage is stepped to negative or positive potential, TRPV2 unitary
conductance remains constant whether 2-ABP or CBD are used as agonist, TRPV2 unitary conductance is
approximately 100 pS, similar to that of Zhang et al report and similar to unitary conductance of TRPV1
(approximately 80 pS)43,106,107.
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Several factors may responsible for different unitary conductance observed. The first factor is presence or
absence of intracellular molecules and axillary proteins. Proteins and lipids such as PI(4,5)P2 and
calmodulin, are known to bind TRPV2 and suggested to enhance TRPV2 current in excised inside-out path
clamp18,124. Pottosin et al and McGahon et al used cell attached configuration to measure stretch activated
TRPV2 unitary current, completely retaining intracellular molecules70,104. On the other hand, reconstitution
of the purified channel in liposome would strip away any auxiliary subunits and potentially cause large
unitary conductance35. In excised inside-out voltage clamp, some molecules will be dilated by bath solution
while others remain. Interestingly TRPV2 unitary conductance becomes large as intracellular molecules
are removed from experimental conditions. Also purified rTRPV2 reconstituted in asolectin liposomes
would remove naturally occurring membrane lipids including cholesterols, sphingolipids, and
phosphoinositide (i.e. PI(4,5)P2), which are shown to modulate gating of TRP channels125. Second, TRPV1
and TRPV3 channel macroscopic current (I) measured in the whole cell voltage clamp configuration are
shown to undergo the process of pore dilation during prolonged agonist or heat stimulation25,98,99. During
pore dilation, TRPV currents are shown to increase over time, and their I-V relation and ion selectivity can
be altered without any additional stimulations25,98,99. Although it is not clear pore dilation affect unitary
conductance of TRPV channels, but it is suggested that pore dilation is a process of spontaneous change in
pore structure. Potentially purified, reconstituted TRPV2 reside in ‘fully dilated’ state that produces large
unitary conductance in liposomes, while TRPV2 channel expressed in the natural membrane is modulated
by intracellular molecules and lipids in the membrane. However, this hypothesis is only a speculation at
this time and further experiment is needed to test if any intracellular molecules and lipids in the membrane
can reduce unitary conductance of TRPV2.
Some other potential causes of the difference in unitary conductance include different agonists used to elicit
TRPV2 current. Pottosin et al and McGahon et al show small and highly erratic unitary current is observed
when membrane stretch are used to activate TRPV270,104, while PBC induced unitary conductance of 304
pS in purified rTRPV2 in liposome35. Interestingly our preliminary result suggests unlike 2-APB and CBD,
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PBC only activates TRPV2 when applied exogenously (data not shown), suggesting PBC may have
different activation process that 2-APB and CBD. However, our result and Zhang et al show that 2-APB,
CBD, and RTx all induced approximately 100 pS current when rTRPV2 are expressed in HEK-293 cells43.
Whether stretch activation and pharmacological activation result in differential TRPV2 unitary conductance
remains to be explored. Also, an argument can be made that the study by Pottosin is performed in Jurkat
cell which is human origin126. Although the significance of species difference on unitary conductance is not
known, human TRPV2 and murine TRPV2 are shown to have different pharmacological profiles32,
illustrating potential species difference in biophysical property of TRPV2. However, this is unlikely since
McGahon et al shows similar high erratic, flickering, small single channel current in rat retinal arterioles.
Finally, the difference in conducting ion must be considered. The study by Huynh et al used K+ as the
charge carrier, whereas all other experiments used sodium Na+ as a charge carrier. However, the effect of
Na+ compared to K+ on unitary conductance is unlikely since related TRPV1 are shown to have smaller
unitary conductance when K+ instead of Na+ are used as main conducting ion127.
Interestingly Zhang et al report strong rectification in unitary conductance; TRPV2 unitary conductance is
103 pS at +90 mV membrane step and 28 pS at -90 mV membrane step43. This result contradicts with ours
and results in rTRPV2 reconstituted in asolectin liposomes, where no rectification of unitary conductance
is observed35. RTx is a TRPV1 selective agonist originally have no affinity to TRPV2. Mutations introduced
by Zhang et al are thought to convert TRPV2 to more TRPV1 like43. Although only four subunit mutation
is needed to create TRPV2-QM, the mutation and usage of RTx as agonist may cause rectification. Unlike
TRPV2, TRPV1 is shown to have rectified unitary conductance121,128, and hence it may not surprising that
TRPV1 like TRPV2-QM develop rectification.
To summarize agonists, mutations, and presence of intracellular molecules may cause variability in TRPV2
unitary conductance, and differential unitary conductance observed in distinct experimental conditions may
provide insight to the biophysical property of TRPV2. However, further examination is needed to elucidate
the cause of different unitary conductance. In the end, our result shows agonist induced unitary conductance
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in wild-type rTRPV2 channel is approximately 90-105 pS under excised inside-out patch clamp
configuration, similar to the unitary conductance of TRPV1. By using commonly used TRPV2 agonists in
the commonly used experimental system, our results provide both useful information for future TRPV2
studies and insight to TRPV2 biophysical properties.

3. Electrostatically charged residues E614 and R619 at S5-S6 loop does not determines TRPV2
unitary conductance
We demonstrated that TRPV2 unitary conductance can be increased by a pharmacological reagent (i.e.
DCPIB). This suggests that TRPV2 pore structure is relatively flexible and can be potentially modulated.
Multiple mutation studies have pointed out alternation of pore structure can drastically affect gating
property. For example, in KcsA channel C-type inactivation process is modulated by a multipoint hydrogenbond network110. TRPV channels are thought to have a similar structure to Kv channels; specifically, they
have similar pore loop and selectivity filter7. As expected similar hydrogen bond structure is found in
TRPV1. Furthermore, this hydrogen bond network has been shown to regulate TRPV1 functions; mutating
charged amino acid residues at E648 and E651 residue to non-charged amino acid residues alters acid
sensitivity129-131 and mutation of K656 lead to alternation in gating properties such as agonist sensitivity
and basal activity of TRPV1132. Two of these residues are conserved in TRPV2, E614 (equivalent to E651
in TRPV1) and R619 (equivalent to K656 in TRPV1) respectively. The structure shows that these two
residues are located at the tip of S5-S6 loop structure facing extracellular matrix. Two residues are located
close to each other which can potentially form a hydrogen bond. This hydrogen bond seems to be able to
stabilize S5-S6 poor loop structure. Interestingly these two residues are not present in TRPV3. TRPV3 does
not seem to have hydrogen bond network at the extracellular tip S5-S6 pore loop. We hypothesized that
TRPV1 and TRPV2 have smaller unitary conductance because of hydrogen bond network at the S5-S6 loop.
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However, mutating hydrogen bond forming subunit R619 to proline did not make TRPV2 channels to
TRPV3 like. The unitary conductance of TRPV2 remain unchanged, and vice versa adding charged amino
acid to S5-S6 pore loop (Q651E-P656R) did not significantly reduce TRPV3 unitary conductance.
The reason for the negative result is unknown. At the time of the experiment, the TRPV2 structure is not
resolved and TRPV3 structure is still not resolved today. Hence, rat TRPV1 structure is used to determine
the structure of TRPV channel poor loop and location of amino acids. Cryo-EM reports purified channel
structures as purification is needed for visualization1,26,29. How does purification process affect the structure
of the TRPV channel is unknown, but as we described in the previous section, single channel activity of
TRPV2 is shown to differ in purified rTRPV2 compared to rTRPV2 expressed in HEK-293 cells;
suggesting a potential difference in pore structure determined by cryo-EM and pore structure of expressed
channel35,43. Furthermore, part of pore turret loop next to S5-S6 loop structure (amino acids 604 and 628)
are removed from TRPV1 in order to resolve the cryo-EM structure of TRPV11,26. How does the removal
of turret loop affect the accuracy of TRPV1 pore structure visualized in cryo-EM is unknown. However,
the comparison between turret loop truncated rabbit TRPV2 structure and full-length rat TRPV2 structure
reveal that full-length rat TRPV2 have wider upper and lower gates and truncation of the pore turret loop
reduced the sensitivity of rat TRPV2 to 2-APB1. On the other hand, truncation of rabbit TRPV2 pore turret
loop did not affect rabbit TRPV2 sensitivity to 2-APB29. It is not known whether observed differences in
size of upper and lower gate and 2-APB sensitivity are species dependent32,96, but rat TRPV2 pore turret
loop is shown to affect agonist sensitivity and potentially affect TRPV2 pore structure. Due to purification
process and truncation of turret loop, it is possible that rat TRPV1 pore loop may have different
conformation than reported, and the charged residues are never close enough to form hydrogen bond
network. The full-length structure of rat TRPV2 shows charged amino acids are located at the tip of TRPV2
S5-S6 pore loop and facing extracellular matrix. The localization of potential hydrogen bond in full-length
rat TRPV2 is farther away from pore loop (Fig 11) compared to truncated rat TRPV1. The hydrogen bond
network in TRPV1 may also locate in a different position than initially estimated and may locate in a
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different position than KcsA. It is possible that difference in positions and conformations result in negative
result.
Our result indicates R619 in TRPV2 and Q651E-P656R in TRPV3 does determine unitary conductance of
TRPV channels. However, other gating mechanisms may be altered by removal or addition of charged
residues at R619 in TRPV2, and Q651E and P656R in TRPV3.Whether mutations affect agonist sensitivity
and channel open duration are to be addressed in the future.

4. Hydrogen peroxide is a co-agonist of TRPV2
The identity of endogenous agonists is one of the greatest question remaining for TRPV2 studies. Multiple
stimuli have been suggested to activate TRPV2 including; mechanical stretch70,104, heat8, membrane
depolarization, PI(4,5)P218, and organic compounds such as 2-APB

27,96

, PBC
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and phytocannabinoids

including Δ9-THC44 and CBD 97. However TRPV2 is not activated at physiological temperature8, and their
endogenous agonist in physiological condition is not known. For example, PI(4,5)P2 is required for 2-ABP
induced TRPV2 current, however, PI(4,5)P2 is not known to activate TRPV2 by itself18. We also
demonstrate membrane depolarization of up to 80 mV did not induce TRPV2 current in BV-2 or in rTRPV2
transfected HEK-293 cells. TRP channels are characterized by their ‘polymodal’ gating, and it is suggested
that multiple stimulations may be needed to activate channel7,22. For the first time, we demonstrate H2O2 is
also a co-agonist of TRPV2. Co-application of CBD and H2O2 enhances TRPV2 NPo but not unitary
conductance. Also, H2O2 by itself did not activate TRPV2 indicating additional stimuli is needed for H2O2
to activate TRPV2. The effect is consistent with the observation in TRPV1. H2O2 is shown to sensitize
TRPV1 to capsaicin and heat, and co-application of H2O2 with other agonist have shown to enhance TRPV1
current91,111,112. Similarly, H2O2 also modulate TRPV486, TRPM287,88, and TRPA189-91 gating. Our results
suggest that a larger TRPV2 current is expected in an environment with high H2O2 concentration.
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This result implies potential biological function of TRPV2. H2O2 is ubiquitously produced in the body, and
its concentration is shown to increase in multiple disease conditions. Physiologically H2O2 is converted
from superoxide (O2•) by superoxide dismutase. O2• is generated by NADPH oxidase on membrane and
electron transport chain in mitochondria133,134. This result suggests that TRPV2 activation is enhanced in an
environment with high ROS. In the central nervous system, ROS is produced following traumatic injury135
and stroke103,136. High level of ROS also associated with the development of neurodegenerative diseases
such as Alzheimer’s disease137 and Parkinson’s disease83,136. In the heart, H2O2 is increased following
ischemia and ROS level directly affect recovery following ischemia138,139. H2O2 also plays important role
in immune regulation. H2O2 production is enhanced during acute and chronicle inflammation, and H2O2
level regulated phagocyte activities75,76,134. Not surprisingly, TRPV2 is found to affect the function of
immune cells and heart cells. Conditional knockout of TRPV2 is shown to reduce phagocytosis in
macrophage64, while application of CBD to BV-2 microglia-like cells increases phagocytosis of aminomodified polystyrene beads67. Furthermore, knockdown of TRPV2 inhibits LPS induced cytokine
production and NF-κB nuclear translocation in macrophage66. Conditional knockout of TRPV2 from heart
result in cardiac dysfunction in 3 day115, while dominant negative suppression of TRPV2 mediated calcium
influx is suggested to prevent muscle dystrophy140.
Despite their effect, H2O2 did not activate TRPV2 by itself, indicating TRPV2 need another endogenous
molecule for activation in physiological conditions. TRPV2 activation in a physiological condition still
remains an enigma despite our finding. It is possible TRPV2 do not have single activator in physiological
condition. Instead, TRPV2 activation may co-regulated by body temperature, membrane depolarization,
H2O2 and potentially membrane stretch, and TRPV2 may remain closed until all conditions are met. For
example, our experiment is conducted under room temperature (18-24ᵒC). Given TRPV2 is a heat sensitive
channel, it is possible that H2O2 may activate TRPV2 at a higher temperature (i.e. 37ᵒC). Normally TRPV2
is activated temperature >53ᵒC8, but co-application of H2O2 may shift the temperature sensitivity to the
physiological range (i.e. 37ᵒC). Whether the combination of H2O2, temperature and membrane

86

depolarization can activate TRPV2 without pharmacological reagents remain to be examined. Also, 1mM
H2O2 is used to enhance TRPV2 activity in the study. However, human body are expected to produce H2O2
in lower concentration. In the physiological condition intracellular concentration of H2O2 is thought to be
1 – 100 nM, while the intracellular concentration of H2O2 is thought to increase to 100 nM – 10 μM133.
Whether lower concentration of H2O2 has the same effect on the TRPV2 need to be addressed in future
experiments. Nevertheless, our study demonstrates a concept that TRPV2 NPo can be modulated by H2O2
and suggests enhanced TRPV2 activity in high ROS environment.

5. Cysteine 206 in ARD and 704 in CTD are required for TRPV2 hydrogen peroxide sensitivity
H2O2 are shown to modify TRPV channel gating, however, the mechanism of regulation remained elusive.
Through single mutations, we identified C206 and C704 are required for TRPV2 H2O2 sensing. If those
two cysteines are replaced by alanine, H2O2 may no longer enhance CBD induced current in TRPV2. Two
residues are located on the cytosolic side of two separate motifs; C206 is located on ARD and C704 is
located on CTD. This result suggests cytosolic H2O2 concentration is important in regulating TRPV channel
function, and both ARD and CTD are involved in H2O2 modulation of TRPV2 gating. Both ARD and CTD
have shown to modulate TRP channel gating. For example, swapping ARD of TRPV1 with TRPV2 have
been shown to convert temperature sensitivity of TRPV1 to TRPV2 and temperature sensitivity of TRPV2
to TRPV1 like34. Similarly, swapping CTD of heat sensitive TRPV1 with CTD of cold sensitive TRPM8
are able to convert TRPV1 to cold sensitive and TRPM8 to heat sensitive141. Those results indicate that
both ARD and CTD are a modulator of temperature dependent activation of TRP channels. Furthermore,
ARD of TRPV2 are shown to modulate agonist sensitivity as swapping ARD of human TRPV2 with ARD
of mouse TRPV2 alters their 2-APB sensitivity32. This result shows 2-ABP binding site can locate near the
C206 in TRPV2, but no direct evidence have been found to indicate the exact location of the 2-APB binding
site. Lastly, the proximal C-terminal region is suggested PI(4,5)P2 binding site needed for PI(4,5)P2
modulation of TRPV1. Specifically, amino acid 682–725 are needed for the PI(4,5)P2 binding28. Together
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those results indicate both ARD and CTD modulate TRPV2 gating, and perhaps it is not a surprise that
cysteines in those two motifs are needed for H2O2 sensitivity in TRPV2. However, it is possible there are
additional cysteines required for H2O2 sensitivity outside of ARD and CTD.
One question remains, whether mutations modulate H2O2 sensitivity or modulate CBD sensitivity and basal
activity of TRPV2. Application of CBD increased wild-type TRPV2 Itail approximately 6 times to that of
the control condition (leak current), and co-application of H2O2 and CBD increased Itail approximately 12
times to that of the control condition (Fig 14). Interestingly, CBD increased C206A mutant TRPV2 Itail
approximately 10 times to that of control condition, and further addition of H2O2 did not enhance CBD
current further. CBD increased C219A mutant TRPV2 Itail approximately 4 times to that of control, while
CBD increased C334 and C704 mutant TRPV2 Itail approximately 7 times to that of control. The question
remains whether mutation alters sensitivity to CBD. For example, it is possible that addition of H2O2 did
not enhance CBD induced C206A rTRPV2 current because C206A mutation itself stabilize open
configuration of rTRPV2 and application of 300 μM CBD achieves maximum Po of rTRPV2. Hence
C206A mutation mimics H2O2 effect instead of abolishes H2O2 effect. Mutations in ARD and CTD have
shown to alter TRP channel sensitivity to agonists. Mutations in ARD of TRPV1 channel have shown to
alters heat, CAP, calmodulin, ATP, and PI(4,5)P245,141. Truncation and mutations of TRPV1 CTD have
shown to alter CAP, pH, and heat sensitivity of TRPV1 channel141,142. In TRPV2 CTD is suggested to be
PI(4,5)P2 binding site and required for PI(4,5)P2 modulation of TRPV218,143. It is possible that mutation in
ARD and CTD of TRPV2 also modulate sensitivity to CBD as well. Whole cell current is determined by
functional channel in membrane (N), unitary current (i) and open probability of the channel (Po; see
equation 6). In our experiment amount of TRPV2 expressed is not controlled, and a number of functional
channel in the membrane (N) can differ from cell to cell. C206A mutant TRPV2 may simply better
expressed (larger N) and result in a difference in CBD induced rTRPV2 current. Currently, whether
mutations affect Po or N is not determined. TRPV2 sensitivity to CBD can be measured by dose-response
experiment in a regulated expression system or in excised inside-out patch clamp where a small number of
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channels (N) are present in membrane patch. Although the effect of the mutation on TRPV2 sensitivity to
CBD is not known, our experiment shows the addition of H2O2 enhances 300 μM CBD induced current in
same cells, where the concentration of CBD remains constant and little change of N is expected.
Furthermore, our result suggests C206 and C704 are required for H2O2 modulation of the TRPV2 activity.
How mutation of C206 and C704 affect H2O2 sensitivity is not known. Interestingly C206 is located near
to C704 of neighboring subunit. Cysteine residue in ARD is suggested to form covalent interaction with
neighboring CTD in TRPV1, linking two neighboring subunit together38. Specifically, C258 in ARD
interact with and C742 on CTD in TRPV138. However, the functional significance of disulfide bond
formation in TRPV1 is not fully understood. In TRPV2 C206 in ARD and C704 in CTD may play a similar
role, suggesting potential disulfide bond formation in TRPV2. However, it is not known if covalent bonding
forms between subunits in TRPV2 at this time. In addition to C206 and C704, TRPV2 contains two
additional cysteine residues, C219 and C334, located in close proximity of the interaction surface (Fig 18
gray space fill plots). However, mutation of C219 and C334 to alanine did not alter TRPV2 H2O2 sensitivity.
The reason for the lack of sensitivity in those two residues are not known, it is possible that two cysteines
are hindered from H2O2 interaction by surrounding amino acids. In addition to C258 and C742, Ogawa et
al indicate C158 and C363 also affect dimerization of the TRPV1 suggesting they also participate in intrasubunit disulfide bond formation38. TRPV2 also contains several cysteines in ARD, including C135, C157,
C364 and more. Their effect on H2O2 sensitivity is not determined at this point.
How do cytosolic motifs such as ARD and CTD regulate TRPV channel opening is not determined. One
theory is that rotation of ARD causes TRPV channel opening29. During heat and agonist mediated activation,
TRPV1 ARD is thought to move close to neighboring CTD and this movement is transduced to S5-S6 pore
loop to open that gate29. This hypothesis is derived from structure analysis of TRPV1 by cryo-EM.
Compared to apo-TRPV1, capsaicin and DkTx bound form of TRPV1, which is thought to be locked in
“open channel state”, shows that ARD is rotated counterclockwise and comes close to CTD of neighboring
subunit4,26. TRPV2 may have a similar mechanism of activation; ARD and neighboring subunit CTD may
89

locate close to each other when TRPV2 is activated. This may explain why H2O2 enhances CBD induced
TRPV2 NPo but by itself does not activate TRPV2. It is possible that agonist is required for C206 and C704
residues close together for H2O2 to function. However whether activation of TRPV channel brings ARD
and CTD of two neighboring subunits close enough to form a disulfide bond, and whether inter-subunit
disulfide bond enhances TRPV NPo is not determined. It is entirely possible that cysteines form intrasubunit disulfide bonds or regulate TRPV gating property thought other mechanisms38.
In addition to C206 and C704, we also report C678 modulate TRPV2 H2O2 sensitivity. C678 is located on
tip of a hook structure unique to TRPV2 (Fig 26)1,29. This hook structure is not found in apo TRPV1 or
DkTx bond TRPV14,26. The hook structure contains multiple ionizable amino acids and one cysteine residue
at the tip. The importance of the hook structure is not previously examined. Interestingly this cysteine
residue is not conserved across species. C678 is conserved in most of the mammals but replaced with
arginine in most of the bird species (data not shown). When C678 is mutated to arginine TRPV2 become
less sensitive to H2O2. This result implies TRPV2 in bird species may have less sensitivity to H2O2 compared
to mammals. The full function of this hook structure is not known, however, this unique structure may
underlie biophysical difference of TRPV1 and TRPV2 such as agonist sensitivity, sensitivity to membrane
stretch, PI(4,5)P2 sensitivity and H2O2 sensitivity18,27,28,50,70,104,106,112.
In summary, our result highlights three cytosolic structures ARD, hook, and CTD is important in H2O2
sensitivity. Especially three cysteines C206, C678, and C704 affect the H2O2 sensitivity of rTRPV2.
However, additional cysteine sites for H2O2 sensitivity as well as mutation effect on TRPV2 agonist
sensitivity need to be examined in the future.
6. TRPV2, but not TRPV1, TRPV3 or TRPA1 is functionally expressed in microglia
Multiple TRP channels are known to be present in the CNS including TRPV1, TRPV2, TRPV4, TRPA1,
TRPM2, and TRPM8144. Of those channels, TRPV161,67 and TRPV463 have been shown to present in mice
brain microglia while TRPV2 are known to present in BV-2 microglia-like cells67. However, the presence
of related TRPV3 and TRPA1 protein and functional expression of these channels are not known as TRP
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channel current response is not fully established in microglia. In this study, we demonstrate that TRPV2
and TRPA1 protein are present in both BV-2 microglia and dissociated neonatal mice microglia, however,
TRPV3 protein is not found in BV-2. Furthermore, we demonstrate TRPV2 current is present in BV-2
microglia-like cells. TRPV2 are likely to be main functional TRPV in microglia.
TRPV2 is important in mediating phagocyte activity. TRPV2 protein is present in macrophage64,65, and
shown to mediate a wide variety of functions including; mediates Ca2+ entry during podosome assembly,
NFKB nuclear translocation, inflammasome assembly, cytokine production, chemotaxis and phagocytosis
in macrophages 64-66,68. Identification of functional TRPV2 expression in those study suggests TRPV2 can
mediate similar function in microglia. Indeed, CBD is shown to increase phagocytosis of BV-2 microglia
like cells67.
TRPA1 is shown to present in brain and suggested to the mediate pain sensation in DRG neurons following
traumatic brain injury145,146. However, their functional expression is not established in microglia. Our result
shows TRPA1 protein in BV-2 and primary microglia, but no current detected by AITC. Similarly, no
TRPV1 current is found in BV-2 and primary microglia despite their protein is detected in both61,67. The
reason for the lack of TRPV1 current may be related to its cellular localization. In brain microglia, TRPV1
is thought to localize mainly in intercellular organelles, specifically shown to localize on mitochondria61,102.
This is consistent with our results that no TRPV1 current is detected by whole cell voltage clamp
electrophysiology in BV-2 and dissociated neonatal mice primary microglia102. TRPA1 localization is not
known, but may also not expressed on the membrane. The trpv2 expression on the membrane is facilitated
by growth factors and chemokines in macrophage65,68. It is possible that TRPV1 and TRPA1 translocate on
plasma membrane with specific inflammatory stimuli, but whether translocation occurs in microglia is not
examined. TRPV1 is suggested to localized on mitochondria and regulate their function. CAP stimulation
induces mitochondrial transition pore formation and cytochrome c mediated cell death of microglia 61.
Furthermore, TRPV1 is shown to promote mitochondrial ROS production and chemotaxis when activated,
but TRPV1 knockdown does not inhibit NO production or cytokine production102,147. Alternatively, TRPV1
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on the membrane may exist in a form not sensitive to CAP. For example, TRPV1 is known to associate
with TRPV3 during heterologous expression in HEK-293 cells10, and associate with TRPV2 in the brain
and when co-expressed in mammalian cell line116,117. Furthermore, TRPV1 is suggested to form heteromeric
TRP channel with TRPA1 in dorsal root ganglion neurons (DRG)148. Formation of heteromeric
TRPV1/TRPA1 channels can modify their sensitivity to agonist. Wild-type mice TRPV1 have CAP
sensitivity of EC50 approximately 9.1 nM149, and TRPA1 have AITC sensitivity of EC50 approximately
11 μM150. CAP sensitivity of heteromeric TRPV1 and AITC sensitivity of heteromeric TRPA1 are not
tested. Potentially more than 100 μM of CAP is needed to activate TRPV1 and more than 20 μM of AITC
are needed to activate TRPA1 in microglia. TRPA1 may also not localized on membrane similar to TRPV1,
or associated with another channel making them insensitive to agonist stimulation. It is possible that more
than 20 μM of AITC may be needed to activate heteromeric AITC in microglia. However, the further
experiment is needed to identify if TRPA1 play a role in microglial physiology.
Our result confirms TRPV2 is main functional TRPV channel present on the membrane of cultured
microglia. This suggests TRPV2 activation will lead to influx of Ca2+ from extracellular fluid. Indeed,
TRPV2 increases calcium influx following the addition of chemokine fMLP and elevated basal calcium
level in the macrophage68. Removal of extracellular Ca2+ abolishes the elevation of basal calcium level in
macrophage, indicating calcium influx is the cause of elevated basal [Ca 2+]i65,68. Furthermore knockdown
of TRPV2 prevents the elevated basal [Ca2+]i following fMLP peptide stimulation suggesting TRPV2 may
regulate chemokine induced rise of [Ca2+]i65,68. Whether TRPV2 in phagocyte are activated by other stimuli
are unknown, however, we demonstrated H2O2 enhances TRPV2 NPo. This would suggest potentially
TRPV2 current is enhanced in the high H2O2 environment and lead to increase of [Ca2+]i in microglia. The
exact function of TRPV2 in microglia is not fully examined. Knockdown of TRPV2 in macrophage have
shown to reduce inflammatory activation, specifically, TRPV2 are needed for phagocytosis64, cytokine
production66, and podosome assembly65,68 and inflammasome assembly151 in the macrophage. It is likely
similar effect will be observed in microglia. Initial data suggests CBD promote phagocytosis of microglia
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via activation of TRPV267 consistent with findings in the macrophage. Further examination is needed to
fully understand TRPV2 function in microglia. Overall we demonstrated that TRPV2 and TRPA1 protein
are present in microglia but only TRPV2 are functionally expressed in plasma membrane, and potentially
modulate the function of microglia.

7. TRPV2 is primed for activation in pro-inflammatory environment
TRPV2 have shown to play important role in phagocytes; they regulate extracellular Ca2+ influx65,68, NFκB nuclear translocation66 pro-inflammatory cytokine production66, and phagocytosis64,67. Our study
demonstrated two facts; TRPV2 is functionally expressed in microglia and TRPV2 current is enhanced by
hydrogen peroxide. Hydrogen peroxide is both product and activator of microglia76. A constant level of
H2O2 is required for maintaining microglia activation while activated microglia produces ROS including
H2O276. These results suggest TRPV2 have increased current in pro-inflammatory activated microglia.
Indeed we demonstrate that LPS pretreated microglia has enhanced microglia activation. We have
demonstrated that LPS pretreatment reduced V0.5, indicating TRPV2 in microglia is activated at more
negative membrane potential after LPS stimulation. Furthermore, LPS pretreatment slowed TRPV2 Itail
decay time, indicating TRPV2 remains in the open state longer after LPS treatment.
However, no statistical difference is found in size of maximum Itail partially dues to large variance between
measurements, and slope factor dx did not change following LPS stimulation, suggesting LPS did not
modulate valance of gating charge. Since Itail is proportional to NPo, this suggests maximum NPo did not
change by LPS pretreatment. The result seems to contradict with our previous finding where the addition
of H2O2 enhanced CBD induced Itail following +80 mV membrane step. One possibility is the large variance.
H2O2 experiments are conducted in the same cell; H2O2 is added to rTRPV2 expressing HEK-293 cells to
enhance 300 μM CBD induced current in the same cell. Under this experimental condition, the number of
channel in the membrane, N, is expected to remain constant. In LPS experiment, a group of LPS pre-treated
BV-2 cells is compared to a group of control media treated BV-2 cells that may contain a different number
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of the functional channel on the membrane. The second difference is the cell used. H2O2 experiments are
performed in rTRPV2 transfected HEK-293 cells while LPS experiment is performed in BV-2. It is possible
that TRPV2 phosphorylation state or PI(4,5)P2 binding may differ in two cells, and furthermore, it is
possible that TRPV2 form heteromer in BV-2 cells. Heteromeric channel formation and auxiliary molecule
binding state of TRPV2 in BV-2 and HEK-293 cells need to be examined in the future. The third difference
is the pro-inflammatory stimuli used. H2O2 and LPS may or may not have same mechanisms of activation.
LPS are known to cause H2O2 production in microglia cells75,76. However, there is no evidence LPS
dependent modulation of TRPV2 gating is mediated by H2O2. LPS may modify TRPV2 channel gating in
addition to H2O2. For example, LPS are shown to activate phosphoinositide 3-kinases (PI3K) pathway and
modulate PI(4,5)P2 concentration152. In turn, the PI(4,5)P2 level can modulate TRPV2 activities18. In
addition to the PI3K pathway, LPS are also known to activate TGF-β-activated kinase 1 pathway and NFκB pathway. The compounded effect of all LPS induced cellular changes on TRPV2 is unknown, and it is
possible this difference in agonist used causes difference in Itail. Also, note that a high concentration of LPS
(2 μg/ml) are used to induce a change in TRPV2 channel gating. High concentration of LPS is used to
activate macrophage-1 antigen (MAC1) receptor and ensures production of H2O275,153. However, even 2
μg/ml LPS are not expected to induce H2O2 concentration as high as 1mM. 100 nM to 10 μM of intracellular
H2O2 concentration are expected during inflammation133. A higher level of H2O2 is thought to induce
apoptosis of the microglia75,133. Lower expected H2O2 concentration in LPS treated BV-2 cells may cause
smaller Itail enhancement in LPS treated BV-2 cells compared to direct application of 1mM H2O2. Also,
note that H2O2 effect is measured by direct application of H2O2, but LPS effect is measured by pre-treatment
of LPS and pro-inflammatory stimuli have been removed at the time of whole cell voltage clamp; potentially
further reducing the amount of H2O2 at the time of electrophysiological measurements. This also suggests
LPS modulated TRPV2 channel gating prior to whole cell voltage clamp. Whether pre-treatment and low
concentration of H2O2 also modulate TRPV2 gating is to be examined in the future. To summarize, our
result shows pro-inflammatory stimulation shift voltage dependent activation of TRPV2 to more negative
potential and retains a population of TRPV2 in the open state longer in BV-2 cells.
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Our result implies that TRPV2 in BV-2 with LPS pretreatment would conduct more current and more likely
to increase [Ca2+]i at any given membrane potential between -40 mV and +70 mV. Increased Itail decay time
also suggest TRPV2 channel activated by membrane depolarization and agonists stimulation will likely to
remain in the open state longer after LPS stimulation. The resting membrane potential of mice microglia
shows two distinct populations. One population of microglia in hippocampal slices have membrane
potential of approximately -23 mV and another population of microglia have approximately -50 mV154. In
cultured mice microglia, the resting membrane potential is approximate -31 mV in one population and -64
mV in the second population154. Our result shows that membrane potential of -20 to -30 mV would activate
approximately 20 – 30 % of LPS pretreated TRPV2, while only 5 – 10% of no-LPS treated TRPV2 would
be activated. This suggests residual TRPV2 current in LPS stimulated BV-2 without the requirement of
further membrane depolarization. This moderate increase of TRPV2 NPo may underline maintaining basal
[Ca2+]i and mediate inflammatory process including, nitric oxide production92, NF-κB nuclear
translocation92, NFLP inflammasome formation94,95 and cytokine production85,92,93. These results suggest
activation of TRPV2 may enhance microglia activation. Microglia is crucial to physiological and
pathophysiological CNS functions. For example, microglia activation is shown to modulate progression
and recovery of neurotrauma81,155, Alzheimer’s disease156,157, Parkinson disease75,153, and multiple
sclerosis158,159. Microglia also maintains synaptic structure by synaptic pruning and synaptic stripping,
indicating alternation of microglia activity can modulate synaptic plasticity during brain development160,161
and impaired microglia activity is correlated to cognitive dysfunctions162. Microglia also maintains the
integrity of blood brain barrier and angiogenesis163. Finally, microglia maintains a healthy environment for
neurons and glia through phagocytosis of damaged and old cells164,165. Microglia has multiple functions in
CNS and it is difficult to predict the effect of TRPV2 activation in the alternation of physiological microglia
function and development of neurological diseases. However, our result suggests TRPV2 activation may
modulate microglia activities and TRPV2 can be a potential therapeutic target for neurological
dysfunctions.
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The exact mechanism of how LPS mediated TRPV2 gating is not known. It is not likely that LPS binds to
TRPV2 directly as no evidence of LPS interaction with TRPV2 is previously published. In our study, LPS
are removed prior to whole cell voltage clamp, and hence there is less probability that LPS is directly
binding to TRPV2 during current measurement. Furthermore, our preliminary result shows the application
of LPS do not enhance TRPV2 current directly (data not shown). Previously we have demonstrated that
H2O2 enhances TRPV2 NPo, which is expected to be produced following pro-inflammatory
stimulations75,76. Application of high concentration of LPS (2 μM) ensures production O2• from NADPH
oxidase trough binding to TLR4 or MAC1 receptor75,76. O2• are converted to H2O2 by superoxide dismutase
which can modulate gating of TRPV2 (Fig 35). Furthermore, LPS treated BV-2 microglia-like cells are
cultured in a high oxygen environment, which can potentially produce a higher level of H2O2 than the
physiological environment. Whether H2O2 is required for LPS modulation of TRPV2 gating is not known,
and whether the physiological concentration of H2O2 modulates TRPV2 gating is not known. It is possible
that LPS modulate TRPV2 through other molecules such as preventing hydrolysis of PI(4,5)P218. The exact
mechanism of LPS modulation of TRPV2 gating needs to be examined in the future. Despite exact
mechanism is unknown, our result reveals TRPV2 is primed for activation following pro-inflammatory
stimulation.
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Figure 35: The working hypothesis of the LPS modification of TRPV2.
LPS binds to receptors such as MAC1 and TLR4. LPS is thought to activate NADPH oxidase complex and
produce O2•. Subsequently. Is converted to H2O2 which enhances TRPV2 activity together with other
endogenous agonists. Enhanced TRPV2 activity would increase Ca2+ influx and promote microglia activation.

8. Summary
The biophysical property of TRPV2 remains poorly understood compared to related TRPV1 despite their
suggested role in multiple physiological processes including osmosensation, mechanosensation, cardiac
cell function, innate immunity, and cancer20,66,70,113-115. Rapid advances in TRPV2 research in recent years
including successful visualization of the TRPV2 structure using cryo-EM and presentation of single channel
activity in liposome have provided insight of TRPV2 biophysical properties. However, a gap of knowledge
still exists. For example, the single channel activity of wild-type TRPV2 was not fully understood, and the
process of TRPV2 activation in physiological condition remained to be an enigma. In this study we
confirmed
1. TRPV2 have fast flickering, erratic activity with subconductance.
2. TRPV2 have a unitary conductance of approximately to 100 pS, similar to TRPV1.
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3. TRPV2 have a constant unitary conductance that is neither affected by negative or positive membrane
steps nor agonist used.
4. TRPV2 single channel property can be modulated by pharmacological reagents such as DCPIB.
5. TRPV2 are functionally expressed in both BV-2 microglia-like cells and neonatal murine primary brain
microglia.
6. Application of exogenous H2O2 is sufficient to potentiate the agonist-dependent activity of TRPV2.
7. Cysteines in ARD (C206), hook structure (C678), and C-terminal loop (C704) are required for H2O2
modulation of TRPV2.
8. Acute treatment of microglia with LPS is sufficient to shift voltage depended activation of endogenous
TRPV2 currents.
In this study, we aimed to contribute to the understanding of TRPV2 biophysical properties by reporting
characteristics of wild-type TRPV2 single channel activities and demonstrated pro-inflammatory stimuli
such as H2O2 and LPS can modulate TRPV2 channel gating and suggests potentially serve as an endogenous
agonist. Furthermore, we identified 3 cysteine residues that modulate TRPV2 H2O2 sensitivity. Although
the exact mechanism of H2O2 and LPS modulation of TRPV2 gating is not fully understood, our results
infer endogenously produced ROS in macrophages and microglia is likely to promote Ca2+ influx through
TRPV2 channels and thereby promote pro-inflammatory phagocyte activation.
However, four major questions remain to be answered.
1. Whether the addition of pharmacological agents such as DCPIB or ROS such as H2O2 modulates
duration of TRPV2 opening. Our result shows that pro-inflammatory stimuli such as LPS treated BV2 microglia-like cells have TRPV2 remain in the open state longer compared to media treated BV-2
microglia-like cells. Dwell time analysis of excised inside-out patch clamp electrophysiology can be
used to examine the duration of channel opening after DCPIB or H2O2 application.

98

2. Whether physiological concentration of H2O2 can enhance agonist induced TRPV2 current. Our result
demonstrates 1 mM H2O2 enhance CBD induced TRPV2 activation. A dose response measurement
H2O2 effect on CBD induced TRPV2 current is needed to elucidate if lower concentration (1 – 10 M)
of H2O2 can also enhance TRPV2 activity.
3. Whether the combination of H2O2 and other endogenous stimuli such as temperature increase and
membrane stretch activate TRPV2. Our result has demonstrated H2O2 alone do not activate TRPV2.
TRPV2 are known to be activated by heating above 53ᵒC and potentially by membrane stretch. It is
possible that H2O2 shifts TRPV2 sensitivity of temperature and stretch; allowing TRPV2 to be activated
by normal body temperature (37ᵒC) and membrane stretch. This can be tested by comparing the TRPV2
current response to temperature ramp and stretch prior and after application of H2O2.
4. Whether inter-subunit disulfide connection is needed for sensitivity to H2O2. Our result identified C206
and C704 are required for TRPV2 sensitivity to H2O2, and study in TRPV1 suggest that two residues
may form an inter-subunit disulfide bond that potentially affects TRPV channel activity38. However,
whether inter-subunit bond forms in TRPV2, and whether inter-subunit disulfide bond is needed for
H2O2 sensitivity is not known. Change in oligomer formation in wild-type TRPV2, C206A mutant
TRPV2 and C704A mutant TRPV2 can be tested by non-reducing western blotting.
5. Whether LPS induced alteration of TRPV2 gating is mediated by H2O2. LPS is known to induce H2O2
production in microglia and we have demonstrated H2O2 enhances TRPV2 activity. LPS can be coapplied with DPI or catalase to prevent or remove H2O2 production in BV-2 microglia-like cells to test
whether is H2O2 production is needed for LPS effect on TRPV2 gating.
In the end, this thesis demonstrates TRPV2 is present and mediate current transduction in microglia,
described rTRPV2 single channel activities, H2O2 enhances TRPV2 NPo and three intracellular cysteine
subunits that are required for TRPV2 sensitivity to H2O2. Although further works are needed to confirm
H2O2 affect TRPV2 NPo in cells and examine the effect of to enhance heat and stretch induced TRPV2
current, our study suggests TRPV2 is sensitized during pro-inflammatory and high redox potential
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environments. Modulation of TRPV2 function can be a potential future drug target for modulation
inflammatory processes.
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